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Chapter 1
Introduction
1.1 Risk factor low birth weight
Low birth weight is defined as weight at birth less than 2500 g (mean birth weight: 3500g)
and very low birth weight with weight at birth <1500 g, regardless of gestational age at this
time point. It is an important indicator of newborns health because of the close relationship
to infant morbidity and mortality. In contrast to this, ’small for gestational age’ (SGA)
defines a newborn smaller in size than normal for the gestational age (<10th percentile for
the gestational age). However, birth weight must be interpreted within the specific popula-
tion, e.g in Indian the criteria for small birth weight is <1500 g (mean birth: 3000 g; (Murki
et al., 2015)). In the USA, the number of newborns with reduced birth weight increased
up to nearly 20% from 1990 to 2006 (Fig. 1.1; (Hamilton et al., 2013)). Within European
countries the increase in low birth weight babies was up to 108% (Spain) from 1980 to 2010
(1.2). Low weight at birth can either occur as result of preterm birth or restricted fetal
growth (UNICEF and WHO, 2004). In the US, the rate of preterm birth declined since 2012
(Martin et al., 2015). Thus, the observed higher percentage of low birth weight newborns
might be caused by an increase in insufficient development and therefore indicates a poor
fetal environment.
The main causes for SGA children are maternal smoking, poor maternal nutrition, young
maternal age, placental dysfunction or infections. These risk factors mainly result in prob-
lems with fetal nutrition and/or oxygenation (Gluckman and Hanson, 2006). An immediate
7
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consequence of low birth weight is neonatal mortality (49.4 death/ 1000 life birth per year;
US, 2013). Furthermore, a number of long-term consequences have been described: Low
birth weight has been associated with cognitive impairments, attention deficits and the need
for special education (McCarton et al., 1996). Furthermore, enhanced risk for cardiovascu-
lar diseases (Rich-Edwards et al., 1997), type 2 diabetes (Harder et al., 2007) and chronic
obstructive airway diseases (Anand et al., 2003) are described. Concerning obesity and dia-
betes, a number of epidemiological studies suggests that maternal nutrition and/or exposure
to maternal glucocorticoids influences later insulin resistance or alterations in insulin secre-
tion (Gluckman et al., 2005). A variety of observations in humans link SGA-children with
an increased sensitivity for growth hormone (GH), insulin and insulin-like growth factor 1
(IGF1) and further with postnatal growth failure (Hofman et al., 1997; Gluckman and Hard-
ing, 1997). This may lead to the underlying pathophysiology of reduced fetal growth and
further diseases (Fall et al., 1995; Gluckman and Harding, 1997).
Figure 1.1: Low and very low birth weight in the US from 1990 to 2012 OECD
Health Data 2012
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Figure 1.2: Low birth weight infants in the year 2010 and the change from 1980
to 2010 Percentage of life birth weight low birth weight (<2500g) and very low birth weight
(<1500g) OECD Health Data 2012
1.2 Low birth weight as cause for low lung function
Barker et al. (1991) reported an association between low birth weight and poor lung function.
Furthermore, they linked lung function deficits with death from chronic obstructive disease in
adulthood. The authors claimed, that intrauterine influences cause retarded fetal weight gain
which than irrecoverably constrains the growth of the airways. Further studies supported
these findings by showing that children with very low birth weight have airway obstruction
(Anand et al., 2003) and reduced lung function with lower diffusion capacity (Hancox et al.,
2009). Very low birth weight was further associated with reduced body weight by the age
of 11 years and lower levels of expiratory flows and forced vital capacities (Kennedy et al.,
2000). In addition, increased hospitalisation of very low birth weight children is mainly due
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to upper and lower respiratory tract infections (Kitchen et al., 1990; McCormick et al., 1980).
The reported respiratory problems of low-birth weight infants often persist into child-
hood with increased respiratory morbidity, including frequent coughing and wheezing (Turner
et al., 2004; McLeod et al., 1996) and may result in reduced lung function during adoles-
cence (Lodge et al., 2014). Even in the absence of those symptoms, there may be subclinical
changes which are linked to airway obstruction, hyperinflation, increased airway reactivity
and exercise limitations (reviewed in Stocks, 2006). These symptoms might improve with
age and somatic growth in some individuals but remain persistent in others. Morgan et al.
(2005) were the first who described that the deficits in lung function in asthmatic, school-age
children (16 years old) was already present at the age of six years and therefore, were not a
consequence of the disease progression. In their longitudinal study the authors showed, that
the children starting with poor lung function (transient early wheezing children) kept this
low level until 16 years of age. Thus, a child with poor lung function at birth will stay at
that level und will not improve to maximal lung function which is normally reached between
20-25 years (Tager et al., 1988). After early adulthood forced exhaled volume in 1 s (FEV1)
is stable up to 10 years and than declines throughout the rest of life. A follow-up study
by Stern et al. (2007) confirmed that children born with low lung function had persistently
low levels of lung function until 22 years of age. In a further approach to investigate the
underlying mechanism, the association of lung function with the reaction to bronchodilators
was tested. In children with low lung function at birth no improvement of lung function
values after the application of the bronchodilator was found. Thus, the authors concluded
that structural changes of the lung and not intrinsic airway hyperresponsiveness caused the
observed airway tracking of lung function from birth onwards. They hypothesize that factors
enrolled in airway development already in utero determine the level of airway function of
the subjects. Similar results were obtained in a longitudinal study which found that persis-
tently wheezing children in childhood continues wheezing until adulthood (26 years) and had
consistently lower pulmonary function than children without wheezing (Sears et al., 2003).
Furthermore, adult individuals with lung function deficits are more prone to develop chronic
obstructive airway diseases (like asthma and COPD; (Weiss and Ware, 1996)). This hypoth-
esis is strengthened by a number of longitudinal epidemiological studies, which showed that
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lung function at childhood is strongly associated with bronchial hyperresponsiveness, low
lung function and persistent asthma by the age of 42 years (Grol et al., 1999b,a; Vonk et al.,
2004) . Svanes et al. (2010) reported that individuals with early life disadvantage (maternal
asthma, maternal smoking, childhood asthma) showed permanently lower lung function and
a slightly larger decline in lung function and a substantially increased COPD risk. Thus, early
life environment has an essential impact on later respiratory health or disease development
(Stern et al., 2007).
1.3 Long term causes of lung function deficits
As mentioned above, reduced lung function in early infancy has a major impact on the
subsequent history of chronic airway disease. The term chronic obstructive airway disease
describes a blockage of the airflow within the lung which is mainly caused by narrowing of
the bronchi (Fig.1.3). Asthma and COPD are grouped in this term and the diseases have
comparable symptoms like shortness of breath, cough, airway remodeling, inflammation and
mucus hyperproduction. However, COPD is a irreversible disease of later life with a rapid
decline in lung function and a high mortality rate (Weiss, 2010). In contrast to this, asthma
is not a fatal disease, seen in early childhood, and is marked by consistent hyperreactivity to
environmental stimuli like allergens and particles (Weiss, 2010).
Figure 1.3: Schematic illustration of a healthy and diseased bronchus
As the underlying pathological features of asthma and COPD are comparable, the treat-
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ment of the diseases is similar. One of the major problems associated with asthma and
COPD is smooth muscle contraction called bronchiospasm (Sakula, 1985). The first ther-
apeutic approach to relax smooth muscle cells was inhalation of the bronchodilator herb
Datura stramonium. This plant can be burned to release the acetylcholine receptor blockers
hyoscyanin and scopolamine which are inhaled. A smooth muscle relaxing effect can also be
achieved by intake of theophylline from tea leaves and coffee (reviewed in Boison, 2011). This
is widely used within low-income countries these days as it is effective and cheap. In 1901
adrenaline was identified as strong bronchodilator and the treatment of asthma with inhal-
able β-adrenoceptors started (Holgate, 2013). Current bronchodilators for the treatment of
asthma and COPD include long-acting β2-agonists (salmeterol, formoterol) and ultra-long-
acting bronchodilators (indacaterol) (Spyratos and Sichletidis, 2015). These drugs combine
sustained smooth muscle relaxation with long duration of action (Crompton, 2006; Beeh and
Beier, 2009). However, the partial efficacy of those substances led to a search for further
drugs, and to the discovery of the anti-inflammatory activity of cortisone (Shampo and Kyle,
2001). Inhaled corticosteroids are of high benefit and the most important medication in
asthma. Nevertheless, they are poorly effective in preventing virus-induced exacerbations
(Doull et al., 1997) and they are useless in steroid-resistant asthma (Leung and Bloom, 2003;
Sher et al., 1994). More fundamentally, these drugs can only cure symptoms and cannot
influence the incidence of the disease as the causes are not treated.
Despite active and successful research on the pathogenesis and development of airway
diseases they can still neither cured nor prevented (The Lancet, 2008). Furthermore, some
patients do not respond to the medication. New insights into the initiation and the origins of
the disease development are urgently needed in order to develop prevention strategies rather
than merely treating the symptoms. For this approach the life course of the diseases have to
be investigated by means of epidemiological studies and basic research.
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1.4 Environmental and maternal influences on the de-
velopment of airway diseases
Several epidemiological observations showed that the prevalence of chronic airway disease
has risen over the past decades (Burr et al., 1989; Anderson et al., 1994). This observation is
most pronounced in the west (Sly, 1999)(reviewed in Beasley et al., 2000). Epidemiological
studies were launched to understand the underlying genetic predisposition and to identify
novel candidate genes by performing linkage studies within families affected by lung function
deficits and gene-wide association studies (GWAS). GWAS identified short-nucleotide poly-
morphism (SNPs) in several genes associated with FEV1 or FEV1/FVC (FEV1/forced vital
capacity)[e.g. TNS1 (Repapi et al., 2010); TGFB2, HDAC4 (Soler Artigas et al., 2011)).
However, these findings cannot explain the increase in prevalence, as genetic alterations like
SNPs are usually visible as phenotype in a population within a much longer time period
than investigated in the underlying studies. Further observations in cohort studies revealed
a higher prevalence in urban than in rural areas, suggesting life style-associated factors to
be important for disease pathogenesis (Ernst and Cormier, 2000; Sly, 1999). Furthermore,
Asher et al. (2006) observed that younger people showed a higher incidence of asthma than
the older age-group indicating a higher airway hyperreactivity After investigating the envi-
ronmental conditions during early life time of the different aged groups, they found adverse
environmental conditions like pollution ect. around birth for the younger people but not for
the older. The fact that environmental conditions in adulthood were comparable between
both groups shows that adverse environmental exposures around birth seem to have an im-
pact. The involvement of different environmental changes might also explain the various
subtypes of asthma and the different severity grades among adults and children, suggesting
that there is an interplay of genetic predisposition and environmental factors. This leads to
the conclusion that complex diseases, like asthma and COPD, might be a consequence of
(mal)-adaptation to changing environments (Guo, 2000).
Barker et al. (1989) were one of the first to describe an association between intrauter-
ine exposure, fetal phenotype and disease development in adulthood (”Fetal origins of adult
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disease”). This hypothesis was strengthened by the observation that the offspring of severe
malnourished mothers, who gave birth after the ”Dutch hunger winter” (1944), suffer pro-
portionally more from obesity, arterial hypertension or diabetes (Heijmans et al., 2008). The
rationale behind that hypothesis is, that the fetus adapts to the intrauterine environment
for later postnatal conditions. However, those adaptations might also be of disadvantage
when the postnatal environment has changed. Several recent cohort studies highlighted the
influence of prenatal environmental changes as risk factor for an altered development leading
to a number of diseases: congenital abnormities in the offspring were linked to intrauterine
herbicide and pesticide exposure (Garry et al., 1996; Yang et al., 2014), preterm birth was
associated with in utero exposure to air pollution (SO2)(Liu et al., 2003; Bobak, 2000) and
smoking during pregnancy has been linked to fetal growth retardation (Ko et al., 2014; Horta
et al., 1997). Thus, exposures during early developmental stages may also increase disease
susceptibility in adulthood as it has been shown for diabetes (Ravelli et al., 1998), chronic
obstructive airway disease (Svanes et al., 2010) and cardiovascular disease (Naess et al., 2013).
Already in the 90th the heritability of poor lung function was observed in twins and the
authors suggested a combinatory effect of individual environmental and genetic variation as
cause (Hubert et al., 1982). An example of gene environment interaction is the effect of
smoking on the GSTT1 gene loci. Low amount of cigarette smoke exposure in a GSTT1 null
genotype background was associated with low lung function in individuals, whereas effect was
found in moderate and heavy smokers (He et al., 2004). This examples illustrate, that lung
function and further chronic airway diseases are modulated by the interaction of individual
environment and personal genetic background.
Since individual genetic variations cannot fully explain the relationship between environ-
mental exposures in early life and disease susceptibility, it is reasonable to consider epigenetic
mechanisms (reviewed in Jirtle and Skinner, 2007). Epigenetic modifications ensure the de-
velopmental plasticity of an organism, which enables the individual to react to environmental
signals by changing their phenotype without alterations in the genetic base (Wolff et al., 1998;
Vasicek et al., 1997). These epigenetic marks can be inherited, have long-term and short-term
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effects and allow a faster adaptation to different environmental changes than genetic alter-
ations. One of the most impressive experimental demonstration of epigenetic mechanisms
came from Waterland and Jirtle (2003). They showed that a methyl-donor-rich diet (folic
acid) of pregnant agouti [A(vy)] mice increased the CpG site methylation at the A(vy) locus.
This change in methylation pattern of the promoter leads to alterations in ectopic agouti
gene expression, which finally alters the offspring phenotype by changing the fur colour (Fig.
1.4). The authors concluded, that even small changes in nutrition during pregnancy can
markedly alter the epigenetic pattern and therefore the gene expression, and lead to quite
different phenotypes in adult offspring (reviewed in Dolinoy et al., 2006).
Figure 1.4: Experimental verification of developmental plasticity Maternal methyl
supplementation changed the coat colour of Avy/a offspring. In case of hypomethylation of
the Avy alleles, offspring phenotype is yellow, which refers to maximal agouti expression.
Whereas Avy hypermethylation lead to silencing of the agouti gene and black fur colour is
visible. (Waterland and Jirtle, 2003)
1.5 Maternal smoking as cause of impaired lung func-
tion
In Europeans countries up to 40% of all women are smoking (WHO 2011) with even around
15-20% of these women are still smoking during pregnancy (Pregnancy Risk Assessment
Monitoring System: PRAMS, USA). Cigarette smoke is composed of around 4000 compounds
including nicotine, carbon monoxide (CO) and poly aromatic hydrocarbons (PAH). These
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toxic substances are also transported to the fetus via the blood stream leading to a 2-fold
higher nicotine concentration in the fetus than in the mother (Koren, 1995). A number of
cohort studies link maternal smoking during gestation with wheezing, intrauterine growth
restriction, preterm birth and poor lung function in children (Svanes et al., 2004; Gilliland
et al., 2000; Kalliola et al., 2013). Furthermore, maternal smoke was also associated with
structural changes in the developing lung (Elliot et al., 1998). Moreover, not only maternal
smoking affected lung function in the offspring, but also grand-maternal smoking elevated
the grandchild’s risk of asthma indicating alterations in lung function in those as well (Li
et al., 2005; Magnus et al., 2015). These changes in lung function in infants might be partly
explained by alterations in gene expression of the developing fetus, which might affect lung
development and maturation (Hafstro¨m et al., 2002; Sekhon et al., 1999). However, despite
educational advertising and anti-tobacco campaigns the number of smoking pregnant women
remain high. Concerning the observed transgenerational effects, even with successful smoking
cessation programs it will take generations to restore the effect of smoking on lung function
and lung disease development within the population. Therefore, it is important to develop
programs to protect the growing fetal lung. For this purpose, the underlying mechanisms of
how cigarette smoke affects fetal and early postnatal lung development need to be understood
in detail.
First human studies investigated DNA methylation pattern to analyse the underlying
causes of poor lung function after in utero CS-exposure. Thus, a study in children revealed
different DNA methylation pattern after intrauterine CS-exposure (Breton et al., 2009). A
current study by Chhabra et al. (2014) demonstrated a link between intrauterine nicotine
exposure and changes in DNA methylation in fetal lung and placental tissues. Both studies
confirm evidence for a modulation of epigenetic marks by cigarette smoke. Further, they
provide a link between changes in DNA methylation with prenatal smoke exposure which
might cause alterations in lung development and lung function deficits leading to chronic
airway diseases.
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1.6 Epigenetic gene regulation
Most importantly, epigenetic marks can determine the functional output of the genome with-
out changing the DNA sequence itself. The term ’epigenetic mechanism’ groups mainly two
process: 1) DNA methylation and 2) histone modifications. DNA methylation occurs at
cytosine-residues converting them to 5-methylcytosine (5-mC). This alteration at CpG-sites
within promoter regions can cause binding of transcriptional repressor proteins and thus
conduct inactivation of the corresponding gene. Changes in DNA methylation pattern by
prenatal exposures are the most studied epigenetic signal in that context and they can affect
global and gene-specific DNA methylation in a tissue-specific and long-lasting manner (Bre-
ton et al., 2009).
Histones are the main structural components of chromatin and changes in the posttransla-
tional modifications of their tails alter chromatin function and dynamics. The best studied
modifications are located at the N-terminus of the histone 3 (H3) and 4 (H4) and are mainly
acetylation, methylation, phosphorylation and ubiquitination 1.5. These modifications are
linked to altered chromatin structure and can also affect binding of effector proteins. A
tight chromatin structure causes genes to be transcriptionally inactive, while an open and
accessible chromatin structure can be found in highly transcribed regions (reviewed in Krebs
and Peterson, 2000). As example, acetylation or trimethylation of H3 on the lysine-residue
4 (H3K4met3) is a mark for promoter regions of active genes and leads to the recruitment
of DNA polymerase II (Vermeulen et al., 2007). Gene repression can be caused by enhanced
chromatin packaging which alters recruitment of repressors like the polycomb repressive com-
plexes PRC1 and PCR2. This recruitment is directed by modification of lysine 27 in H3
(H3K27), either by mono-, di- or trimethylation (Simon and Kingston, 2009). Additional to
modifications of the histone tail, nucleosome composition can alter the response to environ-
mental changes. Mammalian H3 is grouped in two subtypes, the canonical histones (H3.1,
H3.2), which are exclusively expressed during S-phase of the cell cycle and the replacement
histones (H3.3, CENP-A), which are incorporated throughout the cell replication (reviewed
in Biterge and Schneider, 2014). Of note, the non-canonical H3.3 differs from the canonical
H3.2 variant by only one amino acid. Nonetheless, this exchange leads to gene activation
(H3.3) or repression (H3.2; (Hake and Allis, 2006)).
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Figure 1.5: Typical histone modifications in mammals Histone modifications include
acetylation (ac), methylation (me), phosphorylation (ph) and ubiquitination (ub1). Those
modifications occur mainly on the N-terminal tails of histones, with the exception of ubiq-
uitination of the C-terminal tails of H2A and H2B and acetylation and methylation of the
globular domain of H3. Colored ovals represented core part of each histone. K, Lysine; S,
Serine (modified from Bhaumik et al., 2007)
As mentioned above, the Agouti-mouse is the most concrete example of epigenetic mech-
anisms (Waterland and Jirtle, 2003). Not only did that experiment prove the effect of en-
vironmental (nutrition) exposures during gestation on the phenotype of the offspring, but
further demonstrated indirectly the stability of epigenetic marks, as mice at postnatal day
(PND)21 had the same colour than at PND100. Furthermore, heritability was proven as
coat colour in the F2-generation stayed the same, irrespective of the parents (F1)(Cropley
et al., 2006). Feeding with an inhibitor of cytosine methylation (genistein) during pregnancy
results in an altered fur colour and protects the offspring from obesity (Dolinoy et al., 2006),
which demonstrated that prenatal exposures can influence phenotype in adulthood. As the
amount of hypermethylation of the promoter region of the agouti gene was similar in all
three germ layers, the authors infer an effect in very early developmental time points. This
observation highlights the importance of the time point of the environmental influences and
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indicates that embryogenesis is a vulnerable stage, as DNA synthetic rate is high (reviewed
in Dolinoy et al., 2007).
1.7 Lung morphogenises and molecular mechansisms
A recent study by Cuna et al. (2014) linked pulmonary DNA methylation and gene expres-
sion with lung development in humans and mice. The authors investigated lung tissue from
mice with normal development and found a set of genes with inverse relationship between
DNA methylation and expression. Those genes were highlighted as genes which were likely
regulated by DNA methylation and were found to be mainly involved in alveolar septation
process. Further, these genes were related to expression and DNA methylation data from
pulmonary tissue from preterm infants with BPD, which is a human disease with disturbed
alveolar septation. Thus, this publication could connect epigenetic mechanism to lung devel-
opment and further to lung disorders.
In humans lung development starts around three weeks after conception with the laryngo-
tracheal groove from which some days later the lung buds forms (embryonic phase; Fig. 1.6
(Groenman et al., 2005)). Further buds subdivide asymmetrically in two steps resulting in
five buds each for the future lobes. In the pseudoglandular phase the tubulos-acinous gland
starts to develop. The entire air-conducting bronchial tree is built up and coated with cubic
epithelium as precurser cells. The respiratory ducts are formed. The canaliculi branches out
of the terminal bronchioli in the canalicular phase, which is characterized by alterations of
the epithelium and surrounding mesenchym. Then, the acini is surrounded by capillaries
which is the initiation step for later gas exchange. In the saccular phase, the sacculi are
formed and coated with typ I and typ II pneumocytes. Lung development ends by forming
of the alveoli out of the primary septa in infancy.
Lung development of mice is quite similar to those in humans. In the first phase (embry-
onic stage) the lung buds originate as an outgrowth of the foregut. Extensive branching takes
place in the pseudoglandular phase and epithelial tubes are surrounded by mesenchyme. In
the next step, the bronchioles are built up and capillaries arise in close contact with the
cuboidal epithelium. Within the saccular phase alveolar ducts and air sacs are formed. Lung
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development ends with secondary septation and alveolarization at around postnatal day 20
(alveolar phase).
Figure 1.6: Lung development in Human and Mouse The five phases of lung develop-
ment in mouse and human are schematically displayed with corresponding time frame after
conception. E (embryonic day), PND (postnatal day), wk (week)
Thus, lungs are fully mature postnatally. This means that early environmental factors,
either pre- and/ or postnatal, have a significant influence on the course of lung morphogenesis
and maturation.
As lung branching and further development of alveoli, capillaries and distinct cell types is
highly complex a precise regulation of gene expression is needed. First observations concern-
ing development of airway branching were performed in the fruit fly Drosophila melanogaster,
as this organism is quite easy to handle, has a simple physiology and a genetic organization
which allows genetic manipulation (reviewed in Roeder et al., 2012). In the fly, the pep-
tide growth factor branchless (Bnl) was found to be essential for major branching during
embryogenesis (Sutherland et al., 1996) and later, the murine homologue fibroblast growth
factor 10 (FGF 10) was identified (Bellusci et al., 1997). Both genes are produced by the
mesoderm and regulate proliferation of the endoderm, which results in an outgrowth of the
lung bud. Further proliferation and differentiation steps involves signaling of tyrosine kinase
receptors mediated by: platelet derived growth factor (PDGF), vascular endothelial growth
factor (VEGF) and epidermal growth factor (EGF). Additionally, growth factor mediated
signaling by serin threonin receptors includes transforming growth factorβ (Tgfβ) and bone
morphogenic protein (BMP) 4, which opposes proliferation and differentiation (reviewed in
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Desai and Cardoso, 2002). For normal lung development preciprecisely timing of the gene
expression and repression is required. The accurate regulation of those developmental key
genes is only possible due to the extensive combination of DNA methylation and histone
modifications. Disruption of the normal epigenetic modifications in the early development
can alter the gene regulation pattern and may contribute to maldevelopment of the lung
(Joss-Moore et al., 2011).
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1.8 Rationale
The prevalence of chronic obstructive airway diseases, is rising during the past decades and
the costs for medication reach about 200 billion¿per year only in Europe. Current treat-
ments aims symptomatic relief without any curative approaches. Therefore, there is an
urgent need for novel, effective therapies and prevention strategies. However, the underlying
mechanism of the disease development remain entirely elusive so far. Cohort studies suggests
early environmental exposures in prenatal and early postnatal development as one of the
main risk factors to develop chronic lung disease later in life. In this context several risk fac-
tors like parental smoking, parental allergy or chemical exposures were highlighted without
an in depth understanding of the disease-causing pathways. These observations indicate a
transgenerational transmission of disease risk to contribute to the remarkable rises of chronic
airway disease. The emerging field of epigenetic mechanism may provide a link between early
developmental exposures and disease susceptibility and therefore, might be a starting points
for prevention strategies.
Chapter 2
Aims and Objectives
Prenatal smoke exposure is a recognized risk factor for intrauterine growth restriction and
impaired lung function development in children. Furthermore, it has been suggested that
lung function will not improve beyond preschool years. Cohort studies suggested a high
impact of environmental factors at early developmental windows (pre- and postnatally) as
cause for adult diseases. This concept of early origins of disease opens the opportunities
for pre- or early postnatal prevention strategies and therapies. However, to develop such
approaches, the underlying molecular mechanisms need to be investigated. Therefore, this
project aims to establish an intergenerational murine model for maternal smoking during
pregnancy for further studying pulmonary pathways related to the intrauterine exposure. To
allow the translation of findings within that model to human diseases, this murine model has
to replicate the exposure levels and several phenotypic findings from human cohort studies:
 CS-exposure levels similar to those of human smokers
 unaltered parameters of a successful pregnancy as far as possible (e.g.gestational length,
body weight progression of the mother, pregnancy rate, amount of abortions)
 intrauterine growth retardation of the newborns
 catch-up growth after birth
 reduced lung function of the offspring
23
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After sucessfull establishment of the murine smoke exposure model and confirmation of
the phenotypic data, the underlying mechansism can be investigated. Therefore, molecular-
biological methods will be applied to following questions:
Are there CS-related alterations in gene expression in fetal lungs?
Are there CS-related alterations pulmonary signaling pathways?
Are epigenetic mechanisms altered by intrauterine CS-exposures?
25
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Chapter 3
Materials and Methods
3.1 Materials
3.1.1 Chemicals and reagents
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3.1.2 Buffers and solutions
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3.1.3 Buffers and solutions
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3.1.4 Antibodies
3.1.5 Oligonucleotides
3.1.6 Commercial kits
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3.1.7 Consumables
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3.1.8 Devices
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3.1.9 Software
3.2 Methods
3.2.1 Animals
General housing
Seven week old Balb/c mice were obtained from Charles River (Sulzfeld, Germany). Animals
were housed in a specific-pathogen-free (SPF) facility with a 12 h day-night cycle at constant
temperature (20◦C) and humidity (33%). Standard rodent chow and water were provided
ad libitum. The study was conducted under the federal guidelines for the use and care of
laboratory animals und was approved by the Government of the District of Upper Bavaria.
Timed pregnancy
In the age of eight weeks, virgin females were mated with each one proven-breeder male for
24 h. As an accurate pregnancy determination was not possible 24 h after mating, all mice
were initially exposed to cigarette smoke (CS). Mice were weighed every day before starting
the smoke exposure protocol. When pregnancy could be excluded with certainty through
body weight control the smoke exposure of the respective mice was terminated and they
were killed by cervical dislocation. To allow proper implantation of the fertilized oocyte and
CHAPTER 3. MATERIALS AND METHODS 34
to avoid stress, CS exposure or air (AIR) exposure protocol was started from gestational day
(GD) 2.5. CS exposure was performed on 16 consecutive days until GD 17.5 (Fig.3.1).
3.2.2 Cigarette smoke exposure protocol
Mainstream CS was used as surrogate for active smoking. Filter from research cigarettes
3R4F (Tobacco Research Institute, University of Kentucky) were removed and burned within
a modified TE-2 smoking machine (Teague Enterprise; Fig.3.2). Smoke was drawn into the
exposure chamber by a membrane pump. Each day, mice were exposed to ten cigarettes for
50 min, where a pump switched between 2 s cigarette smoke and 4 s air puff. To control the
exposure the total particle concentration was measured by drawing an air sample through
a quartz filter during the 3rd, 6th, 9th cigarette. The difference in the filter weight before
and after the exposure was calculated in relation to the chamber volume. On average,
total particle concentration was 327± 88 mg/m2. Control animals (AIR group) were handled
equally to the CS exposed animals but the cages were kept in a normal air conditioned box
during the time of smoke exposure.
Figure 3.1: Scheme of timed pregnancy and in utero cigarette smoke protocol Eight
week old female mice were exposed daily to mainstream CS starting at gestational day (GD)
2.5 for 16 consecutive days. Fetuses were either delivered by caesarean section (c.section) or
naturally. At the age of postnatal day (PND)21 and PND56 mice were analysed for lung
function
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Figure 3.2: TE-2 smoking machine A: Research cigarettes 3R4F from the University of
Kentucky B: animal chamber C: device for burning the cigarettes
3.2.3 Verification of cigarette smoke exposure
Carbon monoxide hemoglobin level measurement
To verify CS exposure, carbon monoxide hemoglobin level (CO-Hb) was analysed in non-
pregnant mice. To this end, venous blood was obtained from the retrobulbar venous plexus
of anaesthetized animals 30 min after the last cigarette (to allow proper air change after last
cigarette) and analysed by an Hemoximeter (OSM3). As mice needed to be killed after that
analysis, only non-pregnant females were used.
Cotinine analysis
For an independent confirmation of CS exposure urinary cotinine levels were determined by a
Mouse Cotinine ELISA (Calbiotech). Urine was collected from non-pregnant mice four hours
after CS exposure and stored in liquid nitrogen until analysis. The analysis was performed
according to the manufacturer’s protocol. The total cotinine amount was calculated against
a standard curve. Animals did not drink during smoke exposure, to allow water intake, urine
production and nicotine conversion urine was collected four hours after exposure.
3.2.4 Characterization of the offspring
For characterization of the offsprings’s phenotype body and lung weights were noted at
caesarean section (c. section; E18.5; fetus). Further, the lung to body weight ratios were cal-
culated for each animal. To assess body weight development after in utero CS/AIR exposure
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offspring were weighed daily from postnatal day 2 (PND2) to PND18. From PND18 onwards
body weights were determined every week until PND59 (adulthood).
Caesarean section
Offspring were delivered by caesarean section at embryonic day (E) 18.5 for mRNA array
analysis. For other studies, pups were delivered naturally. For c. section, pregnant mice
were anaesthetized by subcutaneous (s.c.) administration of ketamin/xylazin in the neck
fold. After opening the abdomen, the in utero position of viable fetuses and visible resorbed
fetuses were noted. Each fetus was weighed and sacrificed by intraperitoneal (i.p.) injection
of pentobarbital. The lung was removed, weighed (Mettler Toledo) and divided in two parts.
The left lobe was stored in RNAlater (Life Technologies) at 4◦C over night and then at -80◦C
until RNA isolation. The right lobes were directly frozen in liquid nitrogen. The tail was
kept on ice for genotyping.
Lung function analysis
Each litter was divided in two groups of pups: the lung function of group 1 was analyzed
at PND21 and lung function of group 2 was assessed at PND56. After intraperitoneal (i.p.)
injection of 140 mg/ kg ketamine and 7 mg/ kg xylazine mice were tracheotomized and intu-
bated (19G cannula for PND21 pups, 18G cannula for PND56 offspring). For baseline lung
function analysis mice were ventilated with a tidal volume of 11 mL/kg (PND21) or 10 mL/kg
(PND56) at a frequence of 150 breaths/min and a positive end-expiratory pressure of 2 cm
H2O on a computer controlled ventilator (FlexiVent, SCIREQ). The maximal vital capac-
ity (MVC) maneuver was performed. For each mouse, the perturbations were performed
until three acceptable measurements with a coefficient of determination (COD) 0.95 could
be recorded. The mean of the measurements was then related to the body weight of each
individual.
After lung function testing at baseline level, mice were transferred to a Buxco R/C system
(Troy, NY). In order to assess airway hyperreactivity (AHR) in the mice metacholine (MCh)
was nebulized with an in-line nebulizer in increasing concentrations (0, 12.5, 25, 37.5 mg/mL)
for 20 s. Resistance (R) and Compliance (C) were recorded continuously for 3 min and the
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mean was calculated.
3.2.5 Molecularbiological methods
RNA Isolation
Lung tissue was disrupted in Quiazol (Qiagen) by using a bead-based homogenizator (MagNa-
Lyzer, Roche). For total RNA (including small RNAs) isolation the miRNeasy Kit (Qiagen)
was used according to the manufacturer’s protocol.
RNA quality control
RNA quality and quantity were assessed by spectrometry (ND-100, NanoDrop Technologies)
and standard agarose gel electrophoresis. For gel electrophoresis one µg of total RNA was
mixed with 0.6% formamide, 0.5 Ö TBE and SybrGreenII (1:5000) and heated for 15 min
at 65◦C. Afterwards RNA integrity was checked on a native 1.5% agarose gel inspecting 28S
and 18S rRNA bands.
Samples used in Affymetrix Arrays were also checked by capillary electrophoresis (Bioanalyzer
Agilent 2100). For this purpose, only high quality RNA samples (RIN> 7) were used.
3.3 Genotyping
For sex determination of the fetuses, a small piece of tail was used for DNA isolation and
further PCR. To this end, the tail was digested in 200 µL PBND buffer with 2 µL Proteinase
K solution (Roche) at 56◦C overnight. Next, the DNA was precipitated by adding 2.5 Vol
100% EtOH and 0.1 Vol NaOAc (3 M, pH 5.2) and incubated for one hour at -20◦C. After
centrifugation and washing steps with 70% EtOH, the DNA pellet was air-dried at room
temperature and subsequently resolved in water. For the PCR reaction 100 ng DNA, 1ÖTaq
buffer, 2 mM MgCl2, 2 mM dNTPs, 0.4 pmol/µL primer and 0.04µL Taq polymerase (NEB)
were mixed. Target sequence was amplified in a MasterCycler Gradient (Eppendorf, Ham-
burg) according to the protocol table 3.1. The amplified product was mixed with 2Ö loading
dye and visualized on a 2.5% agarose gel. The expected band size for Y-linked allele Kdm5d
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was 226 bp, whereas the size of the X-linked allele of Kdm5d was 255 bp.
Table 3.1: Thermal cycling condition
3.3.1 mRNA profiling
Selection criteria for lung samples
Both androgens and estrogens can influence lung development and lung physiology (Melgert
et al., 2007). To avoid this confounding factor, only lungs from fetuses were chosen, which had
neighbors of identical sex (Fig.3.3). Fetuses with visible abortions within their neighborhood
were also excluded from profiling.
Figure 3.3: Exemplary scheme of the in utero position of viable pups and visi-
ble resorptions at E18.5. Numbers represent viable fetuses, while dots illustrate visible
resorbed fetuses. Selected pups for mRNA profiling are labeled with arrows.
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mRNA profiling
For cDNA amplification total RNA (30 ng, n = 12 per group each six males and females per
group) was used in the Ovation PicoSL WTA System V in combination with the Encore
Biotin Module (Nugen). Amplified cDNA was hybridized on an Affymetrix Mouse Gene ST
2.1 array plate (>28000 coding and <7000 non-coding transcripts). The plates were stained
and scanned according to the Affymetrix expression protocol including minor modifications
as suggested in the Encore Biotion protocol.(This work was done by: Martin Irmler, Institute
of Experimental Genetics, Helmholtz Zentrum Munich)
Statistical transcriptome analysis of mRNA profiling
Expression console (v.1.3.0.187, Affymetrix) was used for quality control and to obtain an-
notated normalized gene-level data (standard settings including median polish and sketch-
quantile normalization). Redundant probe sets with identical expression values in all samples
were removed from the dataset. Statistical analyses were performed by utilizing the statis-
tical programming environment R implemented in CARMAweb (Rainer et al., 2006). The
genewise testing for differential expression was done employing the (limma) t-test. (This
work was performed by: Martin Irmler, Institute of Experimental Genetics, Helmholtz Zen-
trum Munich)
mRNA correlation network
The aim of the functional analysis of a network is to highlight the biological functions and/or
diseases that are most significant to the genes involved in the network. For this purpose
molecular network analysis was carried out using the Ingenuity Database (Redwood City, CA,
USA). MRNA expression data set was loaded into the Ingenuity Pathways Knowledge Base
and a global molecular network was constructed algorithmically based on their connectivity.
A Fischer’s exact test was used to evaluate the significance of the probability that each
biological function and/or disease assigned to that network. (This work was performed by:
Stefan Dehmel, CPC, Helmholtz Zentrum Munich)
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mRNA expression quantification by quantitative RT-PCR
One ng total RNA was converted to cDNA by using the QuantiTect Reverse Transcription
Kit (Quiagen) according to the manufacturer’s protocol. Specific expression patterns were
analysed in 12 ng cDNA with the 1ÖSybrGreen II Master Mix (Roche) on a LightCycler
480 II (Roche; Tab.3.2). Data analysis comprised of baseline and threshold settings by the
LightCycler 480 Software (Roche) and differential gene expression was calculated using the
∆∆ ct-method against TATA-box binding protein (tbp).
Table 3.2: Thermal cycling conditions
3.3.2 Analysis of histone modifications after in utero CS-exposure
Histone isolation protocol
Histones were isolated from frozen lung tissue of E18.5 fetuses. To this end, 500 µL buffer
A1 was added to the tissue which was homogenised by an Ultra-Turrax (IKA) for 10 s on ice
followed by a 2-fold sonification for 10 s with 10% power on ice. The sample was precipitated
(30 min, 4◦C, 15000 rmp) and the pellet was resuspended in 400 µL 0.2 M H2SO4. The acid
extraction was performed at 4◦C by rocking of the samples over night. After centrifugation
(10 min, 4◦C, 15000 rpm), the supernatant was collected and precipitated by adding 145 µL
100% trichloroacetic acid (TCA) followed by incubation on ice for four hours. After centrifu-
gation (10 min, 15000 rpm, 4◦C), samples were washed four times with ice-cold acetone. The
pellet was air-dried at room temperature and resolved in 2 x laemmli buffer, incubated at
65◦C for 15 min and subsequently separated by denaturing gel electrophoresis (15% agarose
gel, 110 V, 60 min). To visualize histone bands, the gel was stained with Coomassie Brilliant
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Blue R-250 (0.1% Coomassie, 10% MeOH, 10% AcOH) for two hours at room temperature
and destained with subsequent changes of destain-buffer (20% MeOH, 10% AcOH) for two
hours. Bands corresponding to histones H3 and H4 were excised from the gel with a sterile
scalpel (Fig. 3.4).
Figure 3.4: Exemplary SDS-PAGE gel from isolated histones from whole lung
tissue Lane 1)recombinant H3 from Escherichia coli, Lane 2) isolated histone from whole
lung tissue from E18.5 fetuses. Excised bands for mass spectrometry analysis are labeled
with thick arrows.
Sample preparation for histone quantification via mass spectrometry
All chemicals used for mass spectrometry (MS) analysis were MS/HPLC grade. Gel pieces
containing histones were washes twice with water and twice with 100 mM NH4HCO3 in order
to adjust the pH value. For destaining, gel pieces were further washed three times with 50 mM
NH4HCO3/ 50 mM acetonitril (ACN) at 37
◦C for 10 min. Afterwards, gel pieces were suc-
cessively dehydrated by subsequent incubation in 100 mM NH4HCO3, 20 mM NH4HCO3 and
three times ACN. Subsequently, samples were digested with trypsin to gain small peptides
which are appropriate for MS analysis. The enzyme digests after unmodified or monomethy-
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lated lysine (K) and arginine (R) residues. The whole digestion would end up in very short
(1-6 amino acid) fragments and analysis would be impractical (Fig.3.5). Therefore, lysine-
residues (K) were protected from digestion by propionylation treatment that modifies un-
modified and monomethylated lysines. Samples were propionylated for 45 min at 37◦C (pH
7-8). To avoid over-propionylation three washing steps with 100 mM NH4HCO3 were carried
out. Afterwards, histones were digested with trypsin (Promega) at 37◦C over night. Tryp-
tic peptides were extracted twice with 70% ACN/0.25% trifluoroacetic acid (TFA)and twice
with ACN. Peptides were concentrated by vacuum centrifugation and the resulting pellet
was resuspended in 0.1% TFA. Histone peptides were desalted using C18-StageTips, eluted
in 80% ACN/0.25% TFA, vacuum concentrated and reconstituted in 0.1% TFA.
Tryptic peptides were injected in a HPLC system (Dionax). Peptides were separated with
a gradient from 5-60% ACN in 0.1% formic acid for 40 min at 300 nL/ min on a C18 col-
umn (75 /textmu L i.d. Ö15 cm, packed in-house with Reprosil Pur C18 AQ 2.4µm; Doctor
Maisch). The eluent was directly electrosprayed into an LTQ-Orbitrap Classic mass spec-
trometer (Thermo Fisher Scientific). Typical MS conditions were spray voltage, 1.5 kV; no
sheath and auxiliary gas flow; heated capillary temperature, 200◦C; MS1 resolution of 7500
(at 400 m/z); normalized collision-induced dissociation energy 35% (MS2) and 45% (MS3);
activation q = 0.25; and activation time = 30 ms.
To allow quantification of modified H3 fragments a spike-in peptide (heavy peptide) was added
to the sample. (This work was done by Ignasi Forne, Zentrallabor fuer Proteinanalytik, Mu-
nich).
CHAPTER 3. MATERIALS AND METHODS 43
Figure 3.5: Trypsin digestion of histone H3 with and without propionylation of
lysine residues Digestion pattern of N-terminal sequence of histone H3 without (A) and with
(B) propionylation. Treatment with propionic anhydrid inhibits trypsin digestion after lysines
and typical tryptic peptides of H3 are created. Arrow marks trypsin cutting site, dashed arrow
marks protected arginine because of following trypsin. Numbers mark aminoacids, underline
demonstrate fragments after digestion.
Protocol to analyse histone modifications obtained by mass spectrometry
The spectra of histone modifications were semi-manually quantified by the Xcalibur software
package (Thermo Scientific). By using the Xcalibur Processing Setup a quantification method
was build that includes the mass-to-charge ratio (m/z) and the expected retention time and
allows the identification of each modification. This generated quantification method was
applied to quantify the data using the Xcalibur Quan Browser. For calculation, the area
below the peak from the extracted ion chromatogram was related to the corresponding spike-
in (Fig.3.6). Further, the sum of all quantified modifications within one sample was calculated
and the amount of each modification was depicted as percentage of all fragments.
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Figure 3.6: Procedure to analyse modified H3 fragments Chromatogram of H3 frag-
ment 9-17, K9,K14 in unmodified form is shown in sample 1. Fragments were identified by
retention time and mass-to-charge (m/z) ratio. Area below the peak in the sample (A) was
related to the area below the peak in the same sample with spike-in (B)
3.3.3 Chromatin-immuno-precipitation (ChIP)
To assess the amount of repressing (H3K27met3)and activating histone modifications (H3K4met3)
at the Igf1 promotor, ChIP experiments were performed by using the SimpleChIP Plus En-
zymatic Chromatin IP Kit (Cell Signaling). In general, the manufacturers protocol was
followed with some minor modifications: as starting material 10 mg frozen lung tissue from
E18.5 pups was used. Each digested chromatin sample was precleared with 20 µL Protein-G
agarose beads before starting the precipitation. The chromatin precipitation was performed
with 5µg chromatin and an antibody concentration according to manufacturer’s specifications
(H3K9met3 and H3K4met3 1:100; H3K27met3 1:75) in a total volume of 500 µL. The elution
volume on the columns after DNA purification was 30µL. Afterwards, enrichment of the Igf1
promotor site was validated by qRT-PCR. One reaction consisted of 1 µL DNA with 5µL
MasterMix (Roche), 0.6µL primermix (Igf1 Prom813) and 3.4 µL H2O. The standard PCR
quantification program was used (Tab.3.2). For quantification the mean of each duplicated
ct-value was calculated. Then, each IP was related to the input sample (%input). This value
was again related to the negative control (precipitation with IgG antibody) of each sample
to assess the fold enrichment.
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3.4 Protein expression analysis
3.4.1 Protein quantification- according to Lowry
A piece of lung tissue was discrupted in 200µL 2 Laemmli buffer (including 1 PhosStop and
2 M urea, freshly added) via sonification (2 x 10 s, 13% power). For protein quantification,
the lysate was diluted 1:200 in H2O and 10 µL per sample was precipitated with 2.5 µL 100%
TCA solution for 30 min at 4◦C. After centrifugation (10 min, 1000 rpm, 4◦C), the pellet
was resolved in 10µL 1 M NaOH, mixed with 31µL Lowry-buffer and incubated for 10 min
at room temperature. This preparation was mixed with 65.5µL Folin-Ciocalteut-reagent
(1:21 dilution) and incubated for another 30 min. The protein amount was calculated by the
absorption at 750 nm and compared to a standard curve.
3.4.2 Protein detection via Western blot analysis
For protein separation a SDS-polyacrylamide gel electrophoresis was performed. 40µg protein
of each sample in a total volume of 10µL was loaded to either a 15% gel (detection of IGF1,
β-ACTIN) or a 7.5% gel (IGF1Rβ, IGF1RβP, αSMA, COL1a1). Gel electrophoresis was
performed in 1Örunning buffer for 90 min at 110 V. Native PVDF membranes (BioRad) were
incubated for five min in methanol before protein transfer. Proteins were transferred to the
membranes for 90 min at 250 mA in 1Ö transfer buffer. After blocking of the membrane with
5% BSA (Sigma) for one hour, it was incubated with antibodies against IGF1 (1:1000 in 5%
BSA), IGF1Rβ, IGF1RβP, αSMA, β ACTIN (all 1 : 1000 in Rotiblock), COL1a1 (1 : 2500 in
Rotiblock). After over night incubation, the membrane was washed three times with TBST
and incubated with HRP-coupled secondary antibody (45 min; 1 : 1000). Another washing
steps were performed (3Öwith TBST) and chemical conversion of substrate was recorded
with a Chemidoc XRS system. Quantification of band intensities was calculated with the
Image Lab software v4.01 and normalized to β-ACTIN (loading control).
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3.5 Statistical analysis
Weight gain of mothers and offspring was analysed using SAS PROCs GLM and MIXED for
repeated measures analyses (SAS Institute Inc. 2011). Analysing the weight gain of animals
over time requires consideration of between groups effects as well as within subject effects.
Growth and groupÖ time interaction parameters were quantified by the natural measure
milligram per day (mg/d) supplemented by 95%-confidence intervals (CI) and p-values. Cor-
responding synoptic graphical display of growths curves for control and exposure groups was
obtained employing SAS PROC GPLOT (performed by Hagen Scherb, Helmholtz Zentrum
Munich).
Molecular data were tested for normal distribution using DA´gostino and Pearson omnibus
normality test (GraphPAD Prism). Mann-Whitney U test or t-test was applied where ap-
propriate. Two-way ANOVA with Bonferroni posttest was conducted for AHR.
Chapter 4
Results
4.1 Establishing a model of prenatal cigarette smoke
exposure
First, exposure to mainstream cigarette smoke was evaluated (blood carboxy-hemoglobin
(CO-Hb) and urine cotinine value). Afterwards, as part of our evaluation of a successful
pregnancy, parameters like maternal body weight development, litter size and pregnancy
rate were assessed.
4.1.1 Characterization of cigarette smoke exposure
To confirm the exposure of the female mice, blood CO-Hb and urinary cotinine (metabolite
of nicotine) levels were explored. As depicted in figure 4.1 cotinine as well as CO-Hb level
were significantly increased in CS-exposed mice compared to control animals. The mean
CO-Hb value (6.3 %) is comparable to human smokers who smoke 11 to 20 cigarettes per day
(Castleden and Cole, 1975). The absolute cotinine values within our model are comparable
to <10 cigarettes/ day in humans (Matsumoto et al., 2013).
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Figure 4.1: Urine cotinine and carbon monoxide hemoglobin level of mainstream
CS-exposed mice. Analysis of CO-Hb (A) and cotinine (B) levels of non-pregnant mice.
Blood withdrawal for CO-Hb measurement was done 30 min after AIR (grey dots)- or CS
(black dots)-exposure. Urine sampling was conducted four hours after CS-exposure. Data of
three independent measurements are shown and statistical analysis was done using unpaired
t-test with ***p≤ 0.001. Bars indicate mean±SD
4.1.2 Pregnancy characteristics
To discriminate between pregnant and non-pregnant mice and to further assess, if CS affects
maternal weight gain in pregnancy, body weights were recorded daily (Fig.4.2). A significant
difference in body weight between pregnant and non-pregnant animals became apparent on
day 12.5 (4.2). In non-pregnant mice CS-exposure resulted in a significant decreased body
weight gain by 80 mg/d compared to control animals (95% CI: 75-84, p< 0.0001; Fig.4.2/A).
Furthermore, regression analysis of the body weight gain over time and exposure revealed
that weight gain in pregnant CS-exposed females was significantly decreased by 157 mg/d
compared to pregnant AIR-exposed females (p<0.0001; 4.2/B).
We wanted to avoid secondary effects due to a compromised pregnancy. Therefore, several
general pregnancy parameters like pregnancy duration, litter size and visible resorbed fetuses
were investigated. As depicted in table 4.1 no difference was observed for pregnancy rates
(12.4± 7.3% in AIR vs 12.6± 8.6% in CS; mean±SD) or pregnancy duration (19.8± 0.6 d in
AIR vs. 20.1± 0.7 d in CS) for both groups. Furthermore, the number of viable pups per
litter of AIR-exposed mothers (5.9± 1.7) was comparable with those of CS-exposed animals
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(5.4± 1.9). No statistically significant difference was seen for the number of visible resorptions
per litter (0.6± 0.8 vs 1.0± 0.8). Likewise, the percentage of male offspring was similar in
CS-exposed and control mice.
Figure 4.2: Body weight development of non-pregnant (A) and pregnant (B) fe-
male Balb/c mice after AIR- or CS-exposure Body weight development of CS-exposed
females is significantly decreased than of AIR-exposed mice (p<0.0001) in the non-pregnant
and pregnant group. Mice were weighed daily before AIR (blue)- or CS (grey)-exposure. The
daily exposure started at day 2.5 and ended at day 17.5 after mating. Data of n≥48 females
(≥ 20 batches) are depicted and statistical analysis was done using regression analysis with
SPSS and were not adjusted for litter size (performed by H. Scherb)
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Table 4.1: Pregnancy Characteristics
4.2 Phenotypic analysis of the offspring
The offspring of AIR- or CS-exposed Balb/c mice were analysed at three distinct time points
of development: embryonic day [E]18.5 (fetal stage), postnatal day [PND]21 (end of breast
feeding, adolescence) and PND56 (adulthood)[Fig.3.1]. Phenotypic assessment included lung
and body weight analyses and lung function analyses. Furthermore, remodeling of the lung
was assessed by expression and protein analysis of αsmooth muscle actin (αSMA) and Col-
lagen1 (Col1).
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4.2.1 Fetal phenotype (E18.5) after intrauterine CS-exposure
Usually, the litter size of mice varies between one to ten pups. Litter size distribution within
our model is shown in Figure 4.3. The allocation of the different litter sizes is comparable
between AIR- and CS-exposed dams and the calculated median is six for both groups. Litter
size might have an effect on nutrition status of the mother and nutrient supply of the pups.
To achieve an uniform distribution of the groups, phenotypic data of the fetuses (E18.5) were
analysed according to litter size larger than six and smaller or equal to six. Figure 4.4 shows
fetal phenotypic data of all animals irrespective of litter size. Female CS-exposed fetuses had
highly significant lower body (0.89± 0.11 g; mean±SD) and lung weights (27.81± 6.62 mg)
compared to control animals (body weight 1.00± 0.16 g and lung weight 33.38± 7.06 mg;
p<0.001). On the other hand, body and lung weight of male offspring were not significantly
affected by intrauterine CS-exposure. After calculation of the lung-to-body weight ratio only
the values for CS-exposed females were significantly decreased in comparison to the values of
AIR-exposed mice (31.10± 5.64 mg
g
in CS vs. 33.45± 4.97 mg
g
in AIR) indicating a relatively
higher deficit in lung growth.
Figure 4.3: Histogram of litter size distribution of viable pups Litter size in percent
of AIR-(gray) and CS-(black) exposed dams with n≥48 per exposure (≥ 20 batches)
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Figure 4.4: Phenotype of in utero cigarette smoke exposed fetuses at embryonic
day 18.5 (all litter sizes included) Body weight (A), lung weight (B) and lung-to-body
weight ratio (C) are displayed according to sex and exposure. Fetuses were delivered by
caesarean section on E18.5 24 h after the last exposure to AIR (gray) or CS (black). Circles
(◦),triangles (4) or diamonds(♦) indicate females, males or both, respectively. Data of n≥31
(≥6 batches) are depicted and statistical analysis was done using Mann-Whitney-U test with
∗∗p<0.01, ∗ ∗ ∗p<0.001
When restricting the analysis to litter size> 6, the body weight of male pups was also sig-
nificantly decreased by intrauterine CS-exposure [Fig.4.5](1.03± 0.13 g in AIR vs. 0.93± 0.08 g
in CS; p<0.05; mean±SD). However, this was more pronounced in females (0.98± 0.16 g in
AIR vs. 0.88± 0.11 g in CS; p<0.01). Looking at litter sizes below or equal to six only
the female body weight was significantly reduced in CS- compared to AIR-exposed animals
(Fig.4.6)(0.92 g± 0.12 vs. 1.07 g± 0.17; CS and AIR, respectively). Lung weight and lung to
body weight ratio were unaffected.
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Figure 4.5: Phenotype of intrauterine cigarette smoke exposed fetuses with litter
size above six Body weight (A), lung weight (B) and lung-to-body weight ratio (C) are
shown according to sex and exposure (AIR [gray] or CS [black]). Circles (◦),triangles (4) or
diamonds(♦) indicate females, males or both, respectively. Data of n≥12 (≥ 6 batches) are
depicted. Statistical analysis was done using Mann-Whitney-U test with *p<0.05, **p<0.01
Figure 4.6: Phenotype of intrauterine cigarette smoke exposed fetuses with litter
size below or equal six Body weight (A), lung weight (B) and lung-to-body weight ratio
(C) are shown according to sex and exposure (AIR [gray] or CS [black]) with a litter size ≤ 6.
Circles (◦),triangles (4) or diamonds(♦) indicate females, males or both, respectively. Data
of n≥12 (≥6 batches) are depicted. Statistical analysis was done using Mann-Whitney-U
test with *p<0.05, **p<0.01, ***p<0.001
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4.2.2 Postnatal body weight gain after in utero CS-exposure
Body weight gain of the pups after intrauterine CS-exposure was followed from PND2 to
PND59. The day of birth was defined as day 0 (Fig.4.7). Analysing of the regression curve
revealed that CS-exposed offspring were significantly lighter than control mice over the time
in both sexes (p<0.001; adjusted for time, litter size and sex, analysis performed by H.
Scherb). However, amount of included animals in this analysis highly differ between early
postnatal days (e.g. PND5: n≥58, ≥12 batches) and later postnatal days (e.g. PND56 n≥5,
≥3 batches). Furthermore, the end of weaning can be seen in a delayed body weight gain
between PND15 to 25. Of note, the interaction of litter size with smoke exposure over time
was not significant and hence was not included in the model.
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Figure 4.7: Body weight development after intrauterine CS-exposure until adult-
hood Body weight is shown according to sex (male (A) and female (B)) and exposure (AIR
[blue]; CS [gray]). In both sexes pups showed significantly reduced body weight gain after in-
trauterine CS-exposure compared to control animals (p<0.001). Assessment of body weight
was done daily beginning at day 2 after birth until day 58. Data of n≥5 (≥3 batches) are
depicted and statistical analysis was done using Analysis of Variance in SAS (performed by
H.Scherb)
4.2.3 Lung function analysis of CS-exposed pups
Lung function parameter in adolescent offspring (PND21)
In order to investigate the effects of intrauterine CS-exposure on lung function, the inspi-
ratory capacity per body weight [Ic/wt] and airway hyperreactivity [AHR] were assessed.
As depicted in Figure 4.8 the inspiratory capacity was significantly decreased in pups af-
ter in utero CS-exposure in both sexes (50.64± 2.71 mL/kg vs. 42.55± 3.44 mL/kg in fe-
males and 47.97± 3.27 mL/kg vs. 43.92± 2.49 mL/kg in males; AIR vs. CS, respectively;
mean±SD). However, a significant increase in AHR after stimulation with metacholine (at
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25 and 37.5 mg/mL) was only present in CS-exposed females compared to control mice
(25 mg/mL: 2.81± 0.12 cm H2O*s*mL−1 in AIR, 3.42± 0.42 cm H2O*s*mL−1 in CS, p<0.01;
37.5 mg/mL: 3.13± 0.21 cm H2O*s*mL−1 in AIR, 3.71± 0.49 cm H2O*s*mL−1 in CS, p<0.01).
Nevertheless, AHR in males showed the same trend but did not reach statistical significance
due to high standard deviation.
Figure 4.8: Lung function analyses of adolescent pups after intrauterine exposure
to CS Inspiratory capacity per body weight (Ic/wt; A) and airway hyperresponsiveness
(AHR; B-C) after metacholine challenge at PND21 after in utero exposure to AIR (grey)
or CS (black). Ic was assessed by flexiVent system, while AHR was measured using an
invasive Buxco R/C. Circles (◦),triangles (4) or diamonds(♦) indicate females, males or
both, respectively. Data of n≥7 (≥3 batches) are shown and statistical analysis was done
using Mann-Whitney-U test with *p<0.05, **p<0.01, ***p<0.001 for Ic/wt and two-way
ANOVA with Bonferroni posttest for AHR
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Lung function in adult mice (PND56)
To assess if lung function deficits track into adulthood, lung function analyses were further
performed at the age of 8 weeks. At this age, all investigated lung function parameters had
returned to normal. Mice showed no effect of intrauterine CS-exposure neither in Ic/wt nor
in AHR after metacholine challenge (Fig.4.9).
Figure 4.9: Lung function analyses of the offspring after at PND56 after in utero
CS-exposure Inspiratory capacity per body weigt (Ic/wt; A) and airway hyperresponsive-
ness (AHR; B-C) after metacholine challenge at PND56 after in utero exposure to AIR (grey)
or CS (black). Ic was assessed by flexiVent system while AHR was measured using an inva-
sive Buxco R/C. Circles (◦), triangles (4) or diamonds(♦) indicate females, males or both.
Data of n≥3 (≥ 1 batches [Ic/wt]; ≥ 3 batches [AHR]) are shown and statistical analysis
were done using Mann-Whitney-U test with *p<0.05, **p<0.01, ***p<0.001 for Ic/wt and
two-way ANOVA with Bonferroni posttest for AHR
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4.2.4 Airway remodeling after in utero CS-exposure
To investigate if airway remodeling occurred after intrauterine CS-exposure, mRNA expres-
sion as well as protein levels of α-smooth muscle actin (α-SMA) and collagen 1 (Col1) were
analysed. Only small changes were observed in Col1 expression in whole lung tissue dur-
ing the different developmental points (Fig.4.10 [A-C]). At PND21 Col1 was significantly
up-regulated without stratifying for sex (fc = 1.4, p<0.05). In contrast, mRNA was down-
regulated (fc = -1.8) at PND56 in male pups with low significance (p<0.05). Nevertheless,
the expression profile is in line with COL1 protein level, where no effect of CS-exposure was
detected in all investigated time points in females. COL1 could not be detected in males.
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Figure 4.10: Expression and protein level of Collagen1 in intrauterine CS-exposed
offspring mRNA (A-C) and protein level (D-F) of Col1 in whole lung tissue on different
developmental points after in utero CS- (black) or AIR-exposure (grey). Expression level
were determined by qRT-PCR with Tbp as reference gene and protein level were calculated
by Western blot analyses with β-ACTIN as reference. COL1 could not be detected on protein
level in male pups. (G) representative Western blot. Circles (◦),triangles (4) or diamonds
(♦) indicate females, males or both. Data of n≥5 (≥5 batches) are shown and statistical
analyses were done using Mann-Whitney-U test with *p<0.05
Besides collagen, α-smooth muscle actin is an important indicator of airway remodeling.
On mRNA expression level of Acta2 no significant effect could be found after intrauterine CS-
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exposure at the investigated growth stages (Fig.4.11 A-C). However, Western blot analyses
revealed an CS-effect in male pups at all observed developmental stages (Fig.4.11 D-F).
Protein level in males of α-SMA was significantly elevated with a fc = 1.4 (p<0.01, E18.5)
and 1.9 (p<0.01, PND21) while a trend for increasing α-SMA can be seen at PND56 (fc = 2.9,
p=0.09) albeit without significance due to high standard deviation.
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Figure 4.11: Expression and protein level of α-smooth muscle actin after in utero
CS-exposure Expression (A-C) and protein level (D-F) of α-SMA in whole lung tissue on
different developmental stages. Expression level were determined by qRT-PCR with Tbp as
reference gene and protein level were calculated by Western blot analyses with β-ACTIN as
reference. (G) representative Western blot. Pups were exposed intrauterine to AIR (black) or
CS (gray) and circles (◦),triangles (4) or diamonds(♦) indicate females, males or both. Data
of n≥4 (≥3 batches)are shown and statistical analyses were done using Mann-Whitney-U test
with **p<0.01
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4.3 Alterations of pulmonary gene expression profile in
CS-exposed fetuses
After having established a murine model of prenatal cigarette smoke exposure and confirma-
tion that the phenotype is comparable to observations made in children, molecular analysis
were performed.
4.3.1 Analysis of mRNA expression profile (performed by M. Irmler
and S. Dehmel)
Within the mRNA array data, three samples (AIR-treatment, one male, two females) were
identified as outliers and excluded from further analysis. Thus, expression data of nine
AIR-exposed and twelve CS-exposed fetuses (3 batches) were used for analysis. All samples
were analysed without filtering by ttest, Limma-ttest or Benjamini-Hochberg for multiple
testing. As we intented to generate hypotheses, we did not wish to exclude data a priori.
Hierarchical Cluster Analysis was applied to probe sets with an average expression >5, but
no sex clustering was observed (Fig. 4.12). Furthermore, only a tendency to cluster according
to treatment could be seen (cluster AIR-exposure: M386, M421, M187, M307; cluster CS-
exposure: M191, M207, M205, F195, F201).
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Figure 4.12: Cluster dendrogram of pulmonary mRNA expression data Hierarchical
cluster analysis was conducted based on probe sets with an average expression> 5. The
horizontal axis (height) represents the distance or dissimilarity in expression pattern between
the individuals. Nine AIR- (Ctrl) and twelve CS- (SMOKE) exposed female (F) and male
(M) fetuses were included.
Based on these findings, no stratification for sex was done in following pathway analy-
sis. From 35916 murine probe sets on the gene chip 26098 could be mapped by Ingenuity
pathway analysis (IPA). For further calculations a |fold-change|> 1.2 and raw p-value< 0.05
was chosen. By using these restrictions 1340 genes were found to be regulated and from
this gene set 1003 could be mapped by IPA. The core analysis modest of IPA was used to
identify causal relationships within the regulated gene set. This core analysis is based on
associations reported in the literature and which are likely relevant for the underlying bio-
logical mechanisms. In this analysis direct and indirect relationships as well as data gained
from experiments with endogenous chemicals were included. Within our data set deregulated
genes showed significant association with several diseases and biological functions. Table 4.2
shows the top 5 associations for three functional groups.
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Table 4.2: Top diseases and bio functions associated with changes in global mRNA
expression patterns
As fetuses are still during their developmental stage, we were mostly interested in molecules
regulated within the functional annotation ”Physiological System Development and Func-
tion”. Interestingly, several subfunctions in this group belong to functional annotations
related to lung and body development (e.g. abnormal morphology of lung, size of body,
morphology of lung cells; Tab.4.3). In a further analysis done by a colleague (Stefan Dehmel;
upstream regulator analysis; IPA; see supplementary data) and in consensus with our pheno-
typic data (body and lung growth alterations) and data in the literature, Insulin-like growth
factor 1 (Igf1 ) was found to be the most abundant gen which was upregulated in our data
set. Additionally, its corresponding binding protein (Igf1bp3 ) was down-regulated within the
data set.
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Table 4.3: Physiological system development and function associated with changes
in global expression patterns
4.3.2 Validation of gene expression data
Only about 5% of the secreted IGF1 is unbound. The majority of IGF1 is bound to its
counterpart IGFBP3 and within this complex IGF1 is transported to the target organ through
the circulation (Butler and LeRoith, 2001). However, only unbound IGF1 can bind to its
receptor (IGF1R) and induce phosphorylation of the receptor, which is essential for further
downstream signaling to activate cell proliferation or prevent cell apoptosis. Thus, besides
IGF1 also IGF1BP3 and IGF1R are important proteins to describe the insulin-like growth
factor system. Therefore, expression level of Igfbp3 and protein amount of Igf1Rβ were
analysed.
As depicted in Figure 4.13 a significant increase in Igf1 was confirmed by qRT-PCR after
in utero CS-exposure on E18.5 (fc=1.3, p<0.05). However, there was no effect on Igf1 in
males. Furthermore, Igf1 expression was not altered at PND21 and at PND56. mRNA
expression of Igfbp3 is shown in Fig. 4.13 D-F. Igfbp3 mRNA was significantly decreased
only in CS-exposed females at E18.5 (fc= -1.6, p<0.05) but not in males nor at the other
time points.
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Figure 4.13: Pulmonary expression data of Igf1 and Igfbp3 Expression levels of
Igf1 (A-C) and Igfbp3 (D-F) are represented as normalized values to the reference gene (Tbp).
Pups after intrauterine CS-exposure (black) or AIR-exposure (gray) at three different devel-
opmental time points (E18.5 [A,D]; PND21 [B,E] and PND56 [C,F] Circles (◦),triangles (4)
or diamonds (♦) indicate females, males or both. n≥6 (≥3 batches). Statistical analyses
were performed by Mann-Whitney-U test with *p<0.05, **p<0.01
4.3.3 Protein quantification of IGF1 at three distinct time points
For further validation of the microarray results at the protein level, Western blot analysis was
performed for IGF1. IGF1 protein level was significantly decreased in males with an fc = -1.4
at E18.5 (Fig. 4.14). On PND21 protein amount was found to be significantly elevated after
CS-exposure in both sexes on PND21 (female: fc =2.0, p<0.05; male: fc = 1.5, p<0.05). In
adult animals (PND56) no differences could be detected. IGF1 protein is 7.5 kDa in size.
Western blot analysis revealed bands at 25 kDa (IGF1-trimer) and 15 kDa (IGF1-Dimer;
4.14G). Those bands were consequently and reproducibly found in all Western blot analysis
and confirmed by the company that produced this antibody. For calculation of the IGF1-
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amount density of both bands was summed up and related to the corresponding β-ACTIN
band.
Figure 4.14: IGF1 protein level in whole lung tissue of offspring after intrauter-
ine CS-exposure Protein data were investigated by Western blot analyses and normalized
against β-ACTIN as reference protein. Further, values are expressed as fold-change according
to the control (AIR). Pups after intrauterine CS-exposure (black) or AIR-exposure (gray) on
three different developmental points (E18.5 [A]; PND21 [B] and PND56 [C] and representing
Western bots (G). Circles (◦),triangles (4) and diamonds (♦) indicate females, males and
both. n≥5 (≥4 batches). Statistical analyses were performed by Mann-Whitney-U test with
*p<0.05, **p<0.01
To further investigate the effect of in utero CS on IGF1 signaling, IGF1Rβ and IGF1RβP
were analysed. The protein level of IGF1Rβ was unaffected in CS-exposed pups in both
sexes with the exception of PND21, where a significant increase of IGF1Rβ was measured in
males (fc = 3.1; Tab.4.15 [A-C]). Whereas IGF1Rβ was highly activated (phosphorylated) at
PND21 in females (IGF1RβP/IGF1Rβ- rato = 1.8; Tab.4.15[D-E]). IG1RβP was not detected
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by Western blot at PND56.
Figure 4.15: Protein level of IGF1-receptor (IGF1Rβ)and its activated form
IGF1RβP Protein data are normalized against β-ACTIN as reference protein and is ex-
pressed as fold-change according to the control (AIR). For quantitative assessment of the
activation, the ratio between IGF1RβP and IGF1Rβ was calculated [D, E]. Pups after in-
trauterine CS-exposure (black) or AIR-exposure (gray) at three different developmental time
points (E18.5 [A]; PND21 [B] and PND56 were analyzed [C] and representing Western bots
(G). n≥5 (4 batches). Circle (◦),triangle (4) or diamond(♦) indicate females, males or both.
Statistical analyses were performed using Mann-Whitney-U test (*p<0.05)
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4.4 Epigenetic regulation by in utero CS-exposure
4.4.1 Global histone modification pattern
The packaging of the DNA highly influences the gene transcription. Posttranslational mod-
ifications of the histone tails can alter the packaging of the DNA and also affects binding
of effector proteins. To analyse global histone modifications in the fetuses after intrauterine
CS-exposure, quantitative mass spectrometry was performed. To this end, histones H3 and
H4 were isolated from whole lung tissue at E18.5. Two batches (each three CS-exposed and
three AIR-exposed pups) were independently analysed.
Results of histone modification analysis are shown in Figure 4.16. No effect of in utero
CS-exposure on global H3 modifications was found. Furthermore, no effect of intrauterine
CS-exposure was measured in H4 modifications (data in appendix).
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Figure 4.16: Quantitative analysis of histon modification pattern in fetuses after in-
trauterine CS-exposure H3 histone of whole lung tissue were isolated. Fragments for mass
spectrometry were generated by propoinylation (protection of lysine-residues [K])and further
digestion by trypsin, leading to fragments: H33 − 8, K4[A];H39 − 17, K9, K17[B];H318 −
26, K18, K23[C];H327− 40, K27, K36, K37[D];H373− 83, K79;H3.3/H3.127− 40[E]. Dia-
monds (♦) indicate females and males. n≥2 (≥2 batches). Statistical analysis was done by
Mann-Whitney-U test
4.4.2 Local histone modification pattern
As Igf1 expression was affected by in utero CS-exposure, we asked, if local histone modifica-
tions at the Igf1-promoter might be changed. Therefore, we analysed activating (H3K4met3)
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and repressing (H3K27met3) histone marks by Chromatin-Immunoprecipitation (ChIP) at
the Igf1-promoter (Fig.4.17). Methylation of H3K4met3 was not altered between CS- and
AIR-exposed fetuses. However, the amount of H3K27met3 was trendwise decreased after
intrauterine CS-exposure in females (p=0.09). No effect on males was measured.
Figure 4.17: Chromatin-immunoprecipitation of Igf1 promoter H3K4met3 and
H3K27met3 modification were enriched by ChIP with the Igf1 promoter in E18.5 fetuses
and the quantification of the product was done by qRT-PCR of the promoter region aqainst
a negative control (IgG antibody). Circles (◦),triangles (4) or diamonds (♦) indicate fe-
males, males or both. n≥5 (≥2 batches). Statistical analysis was done by Mann-Whitney-U
test
Chapter 5
Discussion
Within this study the effect of intrauterine CS-exposure on the development of murine off-
spring was investigated on three distinct developmental time points (E18.5 [fetal stage],
PND21 [adolescent stage] and PND56 [adult stage]). For this purpose, phenotypic data such
as body weight, lung weight as well as lung function analysis and airway remodeling were
assessed. Fetal body and lung weight were significantly decreased after in utero CS-exposure
in female pups. Subsequently, body weight in growing offspring was significantly lowered
after in utero CS-exposure independent of sex. Lung function analysis revealed a CS-related
decrease in inspiratory capacity per body weight in both sexes and an increased airway hy-
perreactivity (AHR) after metacholine challenge in females at PND21. These alterations
were not observed on PND56. Analysis of the pulmonary fetal mRNA expression profiles re-
vealed that Igf1 was significantly upregulated in intrauterine CS-exposed offspring. Further
validation by qRT-PCR confirmed those data. However, fetal protein levels of IGF1 were sig-
nificantly lowered in CS-exposed offspring, whereas in adolescent animals significantly higher
IGF1 levels were observed. Furthermore, histone modification analysis revealed a trend to
reduced methylation at the lysine 27 at histone 3 (H3K27met3; repression mark) at the Igf1-
promoter in female fetuses after intrauterine CS-exposure.
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5.1 Impact of cigarette smoke on pregnancy related pa-
rameters
This study aimed to establish a moderate cigarette smoking protocol, that would not harm
the normal course of pregnancy. To ensure that our protocol mirrors human smoking be-
haviour, cotinine levels and CO-hemoglobin amounts were assessed. Furthermore, we anal-
ysed basic maternal parameters like weight gain, pregnancy duration and litter size to assure
that observed effects in the offspring are caused by intrauterine CS-exposure and not by a
compromised pregnancy.
5.1.1 Cigarette smoke exposure protocol
So far, many murine inter- and transgenerational smoke exposure models are published,
which differ in type of exposure, term of exposure and amount of exposure. Regarding type
of exposure, some models aimed to simulate passive smoking(= sidestream smoke; (Penn
et al., 2007; Rouse et al., 2007)), active smoking (Blacquie`re et al., 2009; Singh et al., 2003)
or used nicotine as surrogate (Liu et al., 2011; Rehan et al., 2012). In terms of exposure
preconceptual (Blacquie`re et al., 2009; Singh et al., 2003), prenatal (Larcombe et al., 2011)
and postnatal (Manoli et al., 2012) (Wu et al., 2009) is applied. Furthermore, the amount
of exposure (times per day and number of cigarettes) varies highly. Also, prenatally exposed
offspring might be challenged with allergens (Singh et al., 2011; Blacquie`re et al., 2009)
[Fig.6.4]. Most of these studies mentioned above did not include CO-Hb or urine cotinine
measurements to validate the CS-exposure. Only Larcombe et al (2011) measured urine
cotinine within their model which consists of mainstream cigarette smoke on second and
third trimester of murine pregnancy (GD 8 to GD 20) with three cigarettes twice per day.
The measured urine cotinine amount of 5799 ng/ mL in CS-exposed dams was 8-fold higher
than the cotinine level reached with our protocol. However, we took urine samples 4 h after
the last cigarette, while Larcombe et al (2011) collected the urine directly after the last
exposure.
Within our study, CO-Hb and urine cotinine values of CS-exposed animals were comparable
to human light to moderate smokers (<1 pack/day; (Schane et al., 2010)) (Matsumoto et al.,
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2013; Hampson and Scott, 2006). According to Chechowska et al (2013) the amount of serum
cotinine correlates with the amount of daily cigarette consumption in humans. Thus, we
hypothesized that the murine CS-exposure model established within this study is comparable
to human mild to moderate smokers. Several studies have already shown that smoking during
pregnancy can affect placental function, which might result in mal nutrition of the fetus (Stone
et al., 2014) and oxidative stress of the placenta (Garrabou et al., 2014). However, the model
presented in this work does not allow to distinguish between direct effects of cigarette smoke
on the offspring and side effects caused by stress or by alterations in placental function
through cigarette smoke consumption.
5.1.2 Influence of CS on course of pregnancy
The gain of body weight during pregnancy of CS-exposed females was significantly reduced
compared to AIR-exposed mice. Despite this effect, other pregnancy parameter such as
pregnancy rate, pregnancy duration, litter size and amount of visible resorptions were not
significantly altered by CS-exposure within this model. In a comparable murine study, preg-
nant mice were exposed to mainstream CS for 4 h/day on 5 day/week with a CO-Hb level
of 25 ppm (human: <1 pack/day) which led to reduced gestational length (0.7 days) in CS-
exposed mice. According to the authors, this reduction was equivalent to a 1.3 week reduction
of gestation in humans indicating a toxic effect of intrauterine CS-exposure causing preterm
delivery (Ng et al., 2006). Our model did not reduce the gestational length. Also Larcombe
et al. (2011) described no effect of intrauterine CS-exposure on the litter size, yet the low
number of investigated pups has to be taken into account (AIR: 3 dams; CS: 4 dams). So far,
a detailed analysis of pregnancy outcome in relation to cigarette smoke exposure has been
poorly investigated in the literature. Carmines et al. (2003) exposed rats to mainstream
CS-exposed and reported a reduced weight gain during pregnancy at particle concentrations
of 600 TPM/m3. Other gestational parameters like litter size and resorptions per litter were
not affected. However, pregnant rats showed a clinical phenotype with diarrhea, salivation
and red eyes caused by CS-exposure. Those effects were not observed in our study.
Along this line it has been reported that smoking pregnant woman, gained about 5 % less
weight than non-smoking women (Groff et al., 1997).
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5.2 Murine phenotypic alterations of the offspring are
comparable to observations in humans
It has been proposed in the literature that environmental exposures during fetal develop-
ment can affect body weight, lung growth and developmental processes (Gilliland et al.,
2001; DiFranza et al., 2004). In humans these alterations can lead to intrauterine growth
restriction (IUR) and preterm birth (Hancox et al., 2009). Additionally, it has been shown
that prenatal CS-exposures results in impaired lung function and increased susceptibility for
chronic airway disease such as asthma and COPD (Hancox et al., 2009; Gluckman et al.,
2005).
5.2.1 Impact of litter size
When comparing murine with human studies the litter size is a major challenge (Priestnall,
1972). Naturally, mice have a litter size between two to ten pups. For this reason phenotypic
data of the pups might differ as nutrient supply per pup will be different. In order to reduce
this confounding factor, fetal phenotypic data were stratified for litter size (litter size>6 and
litter size ≤6) and body weight. Further regression analyses was corrected for sex and litter
size.
5.2.2 Fetal phenotype
Lung weight and lung/body weight ratio after intrauterine CS-exposure were significantly
decreased in female fetuses but there was no obviouse effect on males (litter sizes >6). Re-
duced body weight has already been reported in studies of murine offspring after intrauterine
CS-exposure, but lung weight was not analysed (Larcombe et al., 2011).
These results are in line with human studies (Benjamin-Garner and Stotts, 2013; Caudri
et al., 2007), which described an association between maternal smoking during pregnancy
and low birth weight. However, a recent meta-analysis in humans by Sonnenschein-van der
Voort et al. (2014) proposed that preterm birth caused by intrauterine CS-exposure is the
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reason for low-birth weight within those children. Regarding sex differences, female lungs
mature earlier than males, which could be observed by mouth movements around gestational
week 20 that reflect fetal breathing (Hepper et al., 1997). This indicates an earlier surfactant
production in female fetal lungs (Fleisher et al., 1985), showing that there are sex differences
in lung development that might explain the higher influence of intrauterine CS-exposure in
females.
However, one should bear in mind that nicotine, which is the main psychoactive com-
ponent in cigarettes, interacts with nicotinic cholinergic receptors (nAChR) and leads to
an increase in energy expenditure. In humans it is well known, that nicotine perfuses the
placenta resulting in a 15 % higher nicotine concentration in the fetal than in the maternal
circulation (Eskenazi et al., 1995; Triche et al., 2008). Therefore, nicotine might lead to
increased energy turnover in the fetal organism and could possibly lead to the significantly
reduced weight gain after CS-exposure (reviewed in Shea and Steiner, 2008).
5.2.3 Body weight analysis in growing up offspring
In addition to the results obtained in fetuses, body weight analyses were performed from
PND2 until PND59. Both sexes showed significantly reduced body weight gain in in utero
CS-exposed pups over time. Of note, the number of animals included in weight analysis at
later time points (PND 28-59) is relatively small compared to number of pups analysed in
earlier developmental stages, thus reducing the statistical power of later time points. So far,
to our knowledge, there is no other study in mice that analysed long term body weight pro-
gression after intrauterine CS-exposure. A number of studies using in utero nicotine-exposed
rats showed controversial data regarding long-term body weight development (reviewed in
Abbott and Winzer-Serhan, 2012). The authors conclude that other environmental factors
(e.g. housing conditions, maternal behavior) significantly influence postnatal development
as well, indicating that it is very difficult to restrict causation to CS.
In the present study a delayed body weight gain was observed between PND15 to 21.
This periode corresponds to the end of weaning and the start of individual food intake of the
offspring. Along this line, human cohort studies showed a CS-related delay in growth only in
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early childhood with later catch-up growth (Kanellopoulos et al., 2007; Kotecha et al., 2010).
There are also controversial reports in the literature (Anand et al., 2003).
5.2.4 Lung function measurements after intrauterine CS-exposure
In the present work, intrauterine CS-exposure resulted in reduced inspiratory capacity (after
correction for body weight) in both sexes and a significantly elevated AHR in females at
PND21.
A reduction of thoracic gas volume has been described in intrauterine CS-exposed pups
as well, however without significance after correction for body weight (Larcombe et al.,
2011). The authors further investigated lung mechanics and found elevated levels in tissue
damping (G) and tissue elastance (H) in CS-exposed pups. The authors speculate, that this
might be caused by impaired development and lung size. Similarly, an increased AHR after
smoke exposure has been shown by Blacquie`re et al. (2009). A rat model of intrauterine
nicotine exposure reported increased pulmonary resistance without metacholine challenge
and suggested that the interaction between nicotine and its receptor (nAChR) in developing
lungs might be responsible for alterations in lung mechanics (Sekhon et al., 2001). Pike et al.
(2014) claimed changes in airway smooth muscle after in in utero protein restriction diet as
possible cause for hyperresponsiveness in isolated rat bronchi. Lung mechanics (elastance,
damping) or tissue remodeling might be also involved in the observed reduction in Ic/wt
after CS in the present study. However, the observed AHR might also be explained by an
imbalance in nutrition due to alterations in placental function after CS (reviewed by Shea
and Steiner, 2008).
Studies in school-age children reported a significant association of intrauterine CS-exposure
and reduced lung function, especially in small airway flows (Gilliland et al., 2000, 2001; Svanes
et al., 2004). Furthermore, newborns (4.2 weeks old) already had a significantly reduced lung
function (FEV1) after in utero CS-exposure (Hanrahan et al., 1992). In summary, various
reports in the literature and our own data suggestes that prenatal maternal smoke exposure
affects the in utero airway development and alters lung elastic properties.
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5.2.5 Analysis of airway remodeling in the offspring of CS-exposed
mice
In order to further investigate if lung function deficits can be explained by airway remodeling,
smooth muscle and collagen were analysed on mRNA and protein level. Both proteins are
part of the extracellular matrix and their deposition leads to a thickened airway wall and
markely reduced airway caliber resulting in increased resistance to airflow and bronchial hy-
perresponsiveness (Bousquet et al., 2000). Protein levels of αSMA were significantly elevated
at the fetal stage which was maintained until PND21. In contrast, Acta2 (αSMA) expression
was not altered. Of note, CS-exposure did not influence the mRNA expression or protein
levels of Collagen1. The elevated protein levels of α SMA especially in males might contribute
to the reduction in Ic/wt which was more pronounced in male offspring at PND21, although
the mRNA level was not altered.
Blacquie`re et al. (2009) observed increased amounts of Collagen III and α SMA in adult mice
after prenatal CS and proposed the thickness of α SMA layer as indicator for AHR. However,
the authors used a stronger cigarette smoke exposure (10 cigarettes, twice a day) and already
started cigarette smoking of the dams preconceptionally.
An increase in remodeling proteins is consistent with experiments in in utero nicotine ex-
posed rhesus monkeys where a 1.7 fold increase of collagen surrounding the airways was found
(Sekhon et al., 1999). Regarding human findings, 6 month old babys showed elevated inner
airway wall thickness after intrauterine and postnatal smoke-exposure, which might be based
on increased collagen deposition (Elliot et al., 1998).
5.2.6 Evaluation of the established model regarding phenotypic
analysis
While human data showed a clear correlation between maternal smoking and intrauterine
growth restriction (IUR) as well as an increase in asthma and wheezing of children later
in life (Sonnenschein-van der Voort et al., 2014; Baker et al., 1993), the results available
from animal studies are not consistent regarding intrauterine cigarette smoke exposure and
fetal characteristics. So far, the present, newly established murine model is the first one to
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our knowledge, which shows in depth analysis of pregnancy parameters as well as offspring
phenotypic data from fetal stage until adulthood. It therefore replicates the main findings
made in prenatal children. Furthermore, there are hints for an IUR after smoke exposure
and lung growth was disproportional more affected in female pups. The increase in α SMA
deposition might in part explain the observed lung function alterations (Ic/wt and AHR)
after intrauterine CS-exposure. We speculate that, the observed growth retardations after in
utero smoke exposure might lead to a disturbed lung development and enhanced remodeling,
which, in consequence, might lead to a decline in respiratory function later in life.
5.3 Pulmonary gene expression profile reveals alter-
ations in Igf1
5.3.1 Fetal expression profiling of whole lung tissue
The development of complex diseases such as allergy, cardiovascular disease and diabetes
has been linked to alterations in the expression of multiple genes and trait loci (reviewed
in Andreassi, 2009; Tripathi et al., 2014). Nowadays, gene-environment interactions are in
the research focus for their role in etiology of complex diseases (reviewed in von Mutius,
2009). As being the first environment for the developing fetus, in utero environment has a
high impact on developmental processes in general and consequently on the development of
chronic diseases (reviewed in Dabelea and Crume, 2011; Dolinoy et al., 2006).
This work studied the impact of intrauterine CS-exposure on pulmonary gene expression im-
mediately before natural birth. When analyzing the mRNA expression profiles, no clustering
according to sex and only a trend to cluster for treatment could be observed. However, these
results are in contrast to our phenotypic data, where a clear sex difference in lung weight
and lung/body weight ratio was observed. Within this project overall changes in mRNA
expression were rather snall. As a consequence, even smaller changes caused by sex might
be missed. The differences in gene expression might be explained by the low-to moderate
exposure protocol to avoid high toxic doses. Additionally, the tissue collection was performed
24 h after the last CS-exposure to avoid seeing acute but only transient CS-exposure effects.
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These small changes within gene expression profiles might reflect the early onset of patholog-
ical changes caused by intrauterine CS-exposure, whereas stronger changes might may occur
at the incidence of the disease.
Suter et al. (2011) and (Breton et al., 2009) reported also no clustering according in-
trauterine CS-exposure within their blood and placental tissue from children. The authors
suggested this to reflect multiple interactions among the pathways and genes in the subjects
as possible explanation.
We aimed to identify top diseases and functions associated with changes in global mRNA
expression patterns, by using the core analysis module of the Ingenuity Pathway Analysis
(IPA) software. This analysis revealed that functions associated with organismal develop-
ment were strongly affected by in utero smoking. However, we also observed the groups
’Cancer’ and ’Organismal injury and Abnormalities’ as groups with high p-value. This
might be explained by the structure of IPA. The data basis of IPA is greatly facilitated
by the consideration of prior biological knowledge, in which numerous associations between
molecules, phenotypes and diseases are described (Kra¨mer et al., 2014). As the total amount
of cancer related publications is much higher than e.g. for developmental processes, IPA
shows a higher reference quantity for cancer. Nonetheless, ’Respiratory disease’ was one of
the top hits within the underlying genes as well. Together with the group ’Physiological
System Development and Function’, which included functional annotation like ’Embryonic
Development’ and ’Organ Development’, this gene expression profile provides a molecular
framework which matched the observed phenotypic data (e.g. alterations in lung function
and remodeling). In a further network analysis, Insulin-like growth factor (IGF1) emerged as
developmental key molecule, which could be responsible for the observed phenotypic changes.
The only murine study published so far, that performed pulmonary mRNA expression
profiles after intrauterine CS-exposure was conducted by Rouse et al. (2007). The authors
exposed pregnant mice to sidestream smoke and analysed mRNA expression in 15 week old
offspring. IPA analysis revealed that the significantly regulated genes belong mainly to groups
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like cell proliferation, cell survival, cell metabolism, cytoskeletal structural components and
ubiquitination/ apoptosis. These functional annotations can be groups mainly under the
term ’maintenance’ of the organism, which is in relation to the age of their used animals.
Our data revealed mainly groups globally assigned to ’development’, besides ’Cancer’ as
discussed above, with regards to the fetal stage of the used tissue.
5.3.2 Pulmonary IGF1 levels are altered after intrauterine CS-
exposure
As mentioned above, Igf1 was one of the abundant genes after network analyses, although,
it was not the gene with the highest fold-change and lowest p-value. This growth hormone
was chosen for further analysis in a hypothesis driven way as it has been already described
to correlate with with birth weight in mouse and human (McIntyre et al., 2000; Woods et al.,
1996; Pais et al., 2013). In the present study, the observed up-regulation of Igf1 and down-
regulation of Igfbp3 was confirmed by qRT-PCR in fetuses, while later developmental points
revealed no adverse regulation by CS-exposure. In a further validation step, IGF1 protein
level were assessed by Western blot analysis showing significantly decreased IGF1 level in
CS-exposed fetuses while adolescent CS-exposed pups showed significantly elevated levels.
Igf1 has been thoroughly characterized for its role in tissue development and homeosta-
sis by activating the downstream signaling cascade through binding to the Igf1 receptor
(reviewed in Lee et al., 2014). After receptor binding a complex phosphorylation cascade
activates multiple pathways including mitogen-activated protein kinases (MAPK), proteine
kinase B (PKA, Akt) and signal transducers and activator of transcription (STAT) are acti-
vated. This results in either cell growth and proliferation or inhibition of apoptosis. Postnatal
production of Igf1 is stimulated by growth hormone (GH) in the liver, while fetal Igf1 is pro-
duced in many tissues in a autocrine/paracrine fashion.
The importance of the paracrine action of IGF-binding proteins in the developing lung
was confirmed by Wallen et al. (1997) showing that the expression of the different Igfbp was
cell specific whereas IGFBP peptides were widely distributed in the lung. Further, it was
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shown in rats that the highest IGF1 protein expression was found in early postnatal days
(PD 5-7; alveolar stage) which lead the authors to speculate about the importance of IGF1
in lung development (Liu et al., 2004). Besides the effects of IGF1 on murine lung growth,
there is also evidence that Igf1 is essential for pulmonary cell proliferation and differentiation
(Narasaraju et al., 2006) as well as for lung vasculargenesis of mice (Tanswell et al., 1991).
Furthermore, Igf1−/− mice showed severe embryonic growth retardation with a postnatal
death rate of 100% (Pais et al., 2013).
Accompanying the results in homozygous knock-out mice, a boy, with a homozygous
deletion of the IGF-1 gene, showed severe prenatal and postnatal growth failure (Woods
et al., 1996). Experiments in human fetal and embryonic lung explants demonstrated the
importance of Igf1 on lung vasculargenesis, which is critical for optimal gas exchange after
birth (Han et al., 2003). Expression levels of Igf1 were also drastically elevated in lung mal-
formation in human stillbirths who died because of respiratory distress syndrome [RDS] and
bronchopulmonary dysplasia [BPD] (Chetty et al., 2004; Miyazaki et al., 1998). Further,
several human cohort studies investigated the effect of maternal smoking on the IGF1 levels
in the offspring and found it to be reduced in cord blood after CS (Ingvarsson et al., 2007;
Palmer et al., 2002; Coutant et al., 2001). These data suggest an association of in utero
CS-exposure and alterations in the Igf1 system. Similar to the reversed expression of our
mRNA and protein data on IGF1, Capoluongo et al. (2008) described a similar regulation
pattern in human stillbirth after BPD. The authors observed high protein levels of IGF1
in epithelial lining fluid but low serum IGF-levels. Furthermore, in children with low birth
weight, serum IGF1 levels were dramatically increased at the age of 4 years (Fall et al.,
1995). This increase was even higher than expected for their height and weight. The authors
claimed an adequate postnatal nutrition situation or a postnatal increase in growth hormone
(GH), which modulated Igf1 action, as possible cause for the IGF1 increase. The observed
differences in mRNA expression versus protein level might further be explained by different
regulatory patterns between transcription and translation like half-life of mRNA, translation
rate ect.
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5.3.3 IGF1 downstream signaling
Igf1 acts primarily through its high affinity receptor IGF1R, which results in phosphorylation
of the β-subunit and leads to an initiation of the downstream signaling cascade. Therefore,
also levels of IGF1R and its activated (phosphorylated) form are essential for growth and
lung development. Within our model, IGF1R was significantly up-regulated in males at
PND21 with no change at other developmental points. The receptor activation was also
more pronounced at PND21 in female pups. The lack of changes in IGF1RP/ IGF1R in
males at PND21 might be due to higher receptor protein levels per se, masking the change
in phosphorylated receptors.
The importance of the IGF1R has been shown in IGF1R knock-out mice, which died
shortly after birth from respiratory distress and exhibit pronounced growth deficit (Liu et al.,
1993; Epaud et al., 2012). Furthermore, alterations in the IGF1R gene are associated with
growth effects and IUR or lung hyperplasia in humans as well (Kruis et al., 2010). A deletion
in chromosome 15 was found in an infant with severe IUR and lung hypoplasia. The deleted
region could be specified as gene region of Igf1r and validated by qRT-PCR as a lost copy
of Igf1R.
5.3.4 Conclusion of pulmonary expression data
Lung development in mice sprawls into adolescence with the development of the alveolar
ducts from E17.5 until PND5, and is finished at PND30 with the alveolar stage. Thus, the
Igf1-axis seems not only to be essential for prenatal murine lung and growth development
but also during postnatal lung development. Based on our data, we speculate that in utero
CS-exposure induces a delay in Igf1 protein expression. This delay is abrogated after birth
and leads to a postnatal overproduction of IGF1, which might also explain the intrauterine
growth retardation observed in our model. The alterations in AHR and remodeling markers
of the lung could also be influenced by IGF1 alteration (reviewed in Lee et al., 2014). In
line with these findings, OVA-challenged mice that were treated with an Igf1-antibody to
counteract the Ova-induced up-regulation of pulmonary igf1 expression, showed increased
AHR, airway inflammation and airway wall thickening (Yamashita et al., 2005). Further-
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more, in vitro experiments have shown that IGF1 increases smooth muscle proliferation and
induces SMA contractions. Hoshino et al. (1998) and colleagues analysed bronchial biopsies
from asthmatic patients and revealed an association between Igf1 expression and collagen
thickening. The authors concluded that modulation of Igf1 expression might inhibit inflam-
matory cell infiltration in the airways and therefore, might influence remodeling processes.
Our model suggests that intrauterine CS-exposure results in deregulation of Igf1 expression
as well as of IGF1 protein levels, which may cause reduced neonatal lung weight resulting in
lung function deficits in adolescent mice. Deregulation of the growth hormon axis by prenatal
smoke exposure might be one cause of the observed paediatric phenotype with growth re-
striction and lung function deficits. Furthermore, we speculate, that deregulated Igf1 affects
remodeling processes which leads to increased smooth muscle deposition and may explain
observed AHR after intrauterine CS-exposure.
5.4 Epigenetic changes by intrauterine cigarette smoke
exposure
Epidemiological evidences suggests that early life exposures can be passed on to subsequent
generations. The change of epigenetic marks is proposed as a basic mechanism by which
prenatal exposure could be linked to phenotypic alterations in adulthood. These marks are
reversible, can be inherited (long-lasting effects) and cause changes in gene expression that
can modulate disease susceptibility (reviewed in Jirtle and Skinner, 2007). Epigenetic changes
involve a number of mechanisms including chromatin modifications and DNA modifications.
Histone modifications patterns were investigated within our model to analyse a possible
epigenetic regulation of the Igf1 promoter.
5.4.1 Histone modification pattern
Local histone modifications We aimed to investigate specific histone modifications at
the Igf1 promoter sequence as Igf1 mRNA levels were elevated in CS-exposed fetuses. This
could be due to increased transcription or reduced mRNA degradation of the Igf1 gene. An
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elevated transcriptional rate might be caused by altered histone modifications at the promoter
site. Therefore, common histone marks for actively transcribed genes (H3K4met3) and for
developmentally repressed gene loci (H3K27met3) were investigated by ChIP experiments in
whole fetal lung. No differences in H3K4met3 were observed between both groups. However,
there is a trend to reduced levels of the trimethylated form of H3K27 in in utero CS-exposed
females. Within this context, reduced repression (H3K27met3) of the Igf1 gene might result
in the observed increased in Igf1 mRNA level at E18.5.
Reduced IGF1 protein combined with decreased Igf1 mRNA expression profile in growth
retarded animals was also presented in a food-restriction IGF1-study in rats (Fu et al., 2009).
This mirrors our results and suggestes that both systems are highly influenced by environ-
mental factors. The authors performed a number of ChIP experiments along the histone 3 of
the hepatic Igf1 gene to investigate changes in a gene site-, time- and sex-dependent manner.
Beside other modifications, at postnatal day 21, males showed a significantly elevated levels
of H3K4met3 at the 3’UTR of Igf1 while females showed retarded methylation at H3K36 at
Igf1. Despite the fact, that serum Igf1 levels were decreased, igf1 expression depending on the
lysine, which was analysed, was not altered. The authors concluded that the transcriptional
elongation process was changed by altered histone marks and results in diminished levels
of Igf1. In a follow-up study of the same group, intrauterine food-restricted newborn rats
(PND1) had decreased liver weights associated with reduced H3K4met2 (activating mark) at
the Igf1 promoter (Tosh et al., 2010). However, these analyses were performed in liver tissue.
Thus, Igf1 could be regulated in a different way than lung development. Furthermore, the
intrauterine stress differs from our in utero CS-exposure protocol. Both models affected early
developmental stages and resulted in growth retardation in the offspring and alterations of
Igf1, probably induced by a changed histone code. In a study conducted by Rehan et al.
(2012) acetylation in H3 and H4 were analysed after in utero nicotine exposure in rats. Be-
sides an asthma-like phenotype, a significantly increased acetylation of H3 in lungs and testes
of the F1 offspring was observed. This is another hint that also acetylation of histones might
play a role in lung development.
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Global histone modifications After analysing acetylation and methylation pattern in
H3 and H4 fragments of whole lung tissue no difference between intrauterine CS- to AIR-
exposed offspring could be detected.
As already discussed in our mRNA data, the chosen protocol is rather mild-to-moderate.
Thus, we expected only minor changes in epigenetic marks. It is well known that histones
are modified in a tissue- and cell-specific manner (Cedar and Bergman, 2009), and the use of
lung homogenate as mixture of variouse cell types might therefore mask possible regulation.
Besides the pulmonary global histone modification pattern, there might be an alteration in
other tissues or fluids caused by intrauterine CS-exposure. Furthermore, within this study
whole lung tissue was analysed. This includes the different pulmonary cell types (airway
epithelial cells ATII. ATI, epithelial cells, mesenchmal cells). Thus, histone modifications
might be disguised by differential regulation in each cell typ (Chun et al., 2015). The focus
on a special cell type within the neonatal lungs might reveal more information regarding
histone modifications by in utero CS-exposure in the future.
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5.5 Summary
In humans, prenatal smoking has been related to low birth weight in the offspring. Fur-
thermore, prenatally exposed children show lung function alterations until preschool years.
Cohort studies revealed that lung function either tracks or declines but never improves later
in life. Additionally, in utero cigarette smoke exposed children showed a higher prevalence of
chronic obstructive airway disease such as asthma and COPD later in life, which might result
from reduced lung function. For both diseases only symptomatic medication is available while
curative therapies are lacking. Thus, there is an urgent need to develop novel and effective
therapies and preventive strategies. Although prenatal smoking is well known to negatively
affect the offspring, the underlying mechanisms of the disease development are largely un-
known. Epidemiological studies indicate a transgenerational transmission of disease risk that
might contribute to the rises of chronic airway diseases during the past decades. Further, it
has has been shown that environmental exposures can affect the regulation of essential genes
at developmentally critical points. The emerging field of epigenetic mechanism may provide
a link between early developmental exposures and disease susceptibility and therefore, might
allow intervention and prevention strategies.
The present study aimed to establish an animal model of prenatal exposure to active
maternal smoking in order to be able to investigate the underlying mechanisms. The phe-
notype of our smoke exposed offspring closely resembled observations made in prenatally
exposed children: First, birth weights were significantly reduced. Second, fetal lung growth
was more affected in CS-exposed females pups. Third, lung function deficits were found
after intrauterine CS-exposure in both sexes. Fourth, intrauterine CS-exposure seems to
increase pulmonary remodeling processes (α-smooth muscle actin and collagen deposition).
Therefore, the established murine model appeared to be suitable to investigate molecular
alterations involved in the phenotypic development caused by intrauterine CS. The growth
hormone Igf1 was significantly reduced after in utero cigarette smoke exposure in fetal lung.
Epigenetic studies revealed a non-significant trend for decreased histone 3 tri-methylation at
lysine residue 27 (H3K27met3) at the Igf1 promoter site in whole lung tissue. This histone
mark is associated with silencing processes of developmental genes. However, in this con-
text, reduced tri-methylation at H3K27 might result in an increased mRNA expression of
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the underlying gene. Global histone modification pattern were not affected upon intrauterine
CS-exposure.
In conclusion, the results suggest that prenatal smoking deregulates pulmonary growth hor-
mones and these alterations might be associated with impaired lung function in the absence
of an allergen challenge in adolescents. These results imply that deregulated pulmonary
growth hormones may link prenatal cigarette smoke exposure to increased pulmonary dis-
ease susceptibility. This established model, is the first murine model with in depth analysis of
the outcome of CS-exposure during pregnancy on the maternal and fetal site. Furthermore,
the offsprings phenotype was investigated longitudinally which allows comparison to human
situation from the newborn until adulthood. This study suggesting a direct association be-
tween intrauterine CS-exposure, postnatal lung function deficits and alterations in a growth
hormone which might be caused by changes of the histone code. However, our model allows
not to separate effects of intrauterine growth retardation and prenatal CS-exposure on the
lung. Although no difference was observed in pregnancy related parameters, we can not ex-
clude that placental function was affected by CS-exposure. Furthermore, CS-exposure might
be an additional stress factor which influences pregnancy, which can not be counteracted by
similar handling of control and CS-exposed mice.
A number of questions remain open: Does CS-exposure alter the downstream signaling
(MAPK, AKT or STAT)? Can the deregulation of IGF1 by CS-exposure passed on to the
next generation (F2) without additional exposure of F1? Is DNA methylation altered by CS-
exposure? Can the diminished methylation on H3K27 which was observed in this model be
increased by histone-methyltransferases (HMTs) and therefore increase the Igf1 expression
in utero? Thus, further studies are needed to further understand the mechanisms underlying
lung function deficits caused by prenatal smoking.
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5.6 Zusammenfassung
Die Hauptursache von geringem Geburtsgewicht bei Neugeborenen ist das Rauchen der Mut-
ter wa¨hrend der Schwangerschaft. Diese pra¨natal exponierten Kinder zeigen zudem eine
verringerte Lungenfunktion im Vorschulalter. Die maximale Lungenfunktion wird etwa im
Alter von 22-24 Jahren erreicht. Epidemiologische Studien zeigten, dass das Lungenfunk-
tionsmaximum entweder konstant schlecht bleibt oder sogar abnimmt, sich jedoch nicht
verbessern wird im weiteren Verlauf des Lebens. Weiterhin wurde belegt, dass die Pra¨valenz
von chronisch obstruktiven Lungenerkrankungen, wie Asthma und COPD, in Kinder von
rauchender Mu¨ttern deutlich erho¨ht ist. Dieser erho¨hte Pra¨valenz ist mo¨glicherweise auf
eine verringerte Lungenfunktion zuru¨ck zu fu¨hren. Bis jetzt gibt es fu¨r oben genannte Lun-
generkrankungen nur eine medikamento¨se Behandlung der Symptome jedoch keine Heilung.
Somit ist die Entwicklung neuer Behandlungsmo¨glichkeiten unabdingbar. Ein besonderes
Augenmerk liegt dabei auf praventiven Therapien. Insbesondere fu¨r pra¨ventive Massnah-
men mu¨ssen jedoch die zugrunde liegenden Mechanismen bekannt sein. Studien im Rahmen
humaner Kohortstudien zeigten, dass die Exposition mit verschiedenen Umweltfaktoren in
fru¨hen Entwicklungsstadien (pra¨natal und postnatal) mit einem deutlich erho¨hten Risiko fu¨r
chronische Lungenerkrankungen im Erwachsenenalter einhergeht. In diesem Zusammenhang
wurden verschiedene Faktoren wie elterliches und grosselterliches Rauchen, elterliche Allergie
und Erna¨hrung wa¨hrend der Schwangerschaft aufgekla¨rt. Die direkten Zusammenha¨nge
sind jedoch unbekannt. Die Beobachtung, dass nicht nur die Kinder (F1) sondern auch
die Enkel (F2) ein erho¨htes Risiko fu¨r Lungenerkrankungen nach mu¨tterlichem Rauchen
zeigen, deutet auf eine inter- und transgenerationale Weitergabe des Krankheitsrisikos hin.
Da eine geringe Exposition von Umwelteinflu¨ssen nicht direkt zu einer Mutation der zu-
grundeliegenden Gensequenz fu¨hrt und damit den Anstieg an Lungenerkrankungen erkla¨ren
wu¨rde, werden epigenetische Mechanismen hinter diesem Anstieg vermutet. Das Gebiet
der epigenetischen Mechanismen stellt eine Verbindung zwischen Exposition in fru¨hen En-
twicklungsfenstern und Krankheitsanfa¨lligkeit her und ko¨nnte deshalb ein Ansatzpunkt fu¨r
Pra¨ventionsstrategien sein.
In diesem Projekt sollte ein Mausmodel zur mu¨tterlichen Rauchexposition wahrend der
Schwangerschaft etabliert werden, welches dem humanen Pha¨notyp weitestgehend entspricht.
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Erste pha¨notypische Charakterisierungen der Nachkommen zeigten ein reduziertes Lungen-
und Ko¨rpergewicht, eine verringerte Lungenfunktion sowie eine gesteigerte Hyperreaktivita¨t
der Bronchien. Weiterhin konnte ein vermehrtes Auftreten von glatter Muskulatur (a-SMA)
gefunden werden, welches auf Remodellierungsprozesse hindeutet. Analysen der fo¨talen, pul-
monalen Genexpression zeigten eine signifikant verringerte Expression des Wachstumshormones
IGF1 der rauchexponierten Nachkommen. Epigenetische Analysen der Histonmodifikationen
zeigten einen Trend an verringerterm trimethyliertem Lysin 27 des Histons H3 (H3K27met3)
am Igf1 Promoter. Diese Histonmodifikation ist bekannt fu¨r eine Repression der Translation
des zugrunde liegenden Genes. Die damit verbundene Erho¨hung der mRNA an Igf1 konnte
in den rauch-exponierten Fo¨ten besta¨tigt werden.
Zusammenfassend la¨sst sich sagen, das anhand der Ergebnisse dieses Mausmodells ein direk-
ter Zusammenhang zwischen intrauteriner Zigarettenrauch-Exposition, verringerter Lungen-
funktion und dereguliertem Wachstumshormon IGF1 im Jugendlichem zu bestehen scheint.
Nach unserem Wissen, ist dieses Mausmodell das erste, welches eine grundlegende Analyse
der mu¨tterlichen und fo¨talen A¨nderungen nach prenatalem Rauch durchfu¨hrt.
Die Mo¨glichkeiten unseres Modells erscho¨pfen sich jedoch darin zu kla¨ren, ob die verringerte
Lungenentwicklung eine Folge des verringerten Wachstums oder eine direkte Folge des mu¨tter-
lichen Rauchens ist. Weiterhin kann die Prozedur des Rauchens an sich zu stressbedingten
A¨nderungen in der Entwicklung fu¨hren. Zudem bleiben noch eine Reihe offener Fragen: Hat
in utero Zigarettenrauch auch Einfluss auf die Signaltransduktionswege unterhalb von IGF1
(AKT, STAT, MAPK)? Wird die vera¨nderte Regulation von IGF1 auch an die na¨chste Gen-
eration (F2) ohne zusa¨tzliche Rauchexposition weitergegeben? Sind andere epigenetische
Mechanismen, z.B. DNS-Methylierungen, durch Rauchexposition vera¨ndert? Weitere Unter-
suchungen sind no¨tig, um die zugrunde liegenden Mechanismen der Lungenfunktionsdefizite
durch pra¨natalen Zigarettenrauch zu erkla¨ren.
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